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ABSTRACT
Parkinson’s disease (PD) is a debilitating neurodegenerative disorder affecting
one million Americans. Despite its social and economic impact, the pathological
cascades that lead to neuron dysfunction and degeneration in PD are poorly
understood. Endoplasmic reticulum (ER) stress has been implicated as an initiator or
contributing factor in neurodegenerative diseases including PD. The ER is an organelle
central to protein folding and intracellular Ca2+ homeostasis. Perturbations of these
functions result in ER stress and upregulation of ER stress proteins, of which some
have been implicated in counteracting ER stress-induced cell death. The mechanisms
that lead to ER stress and how ER stress proteins contribute to the degenerative
cascades remain unclear but their understanding is critical to devising effective
therapies for PD. Both the accumulation of mutant -synuclein (Syn), which causes an
inherited form of PD, and the inhibition of mitochondrial complex I function by PDinducing neurotoxin lead to ER stress. The critical involvement of ER stress in
experimental models of PD supports its potential relevance to PD pathogenesis and led
us to test the hypothesis whether the homocysteine-inducible ER protein (Herp), an
ubiquitin-like domain (UBD) containing ER-resident protein, can counteract mutant
Syn- and neurotoxin- induced pathological cascades.
In the first part of my study I showed that knockdown of Herp aggravates ER
stress-mediated cell death induced by PD-linked mutant Syn. Functionally, Herp plays
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a role in maintaining ER homeostasis by facilitating proteasome-mediated degradation
of ER-resident Ca2+ release channels in a neuronal-like cell line expressing the mutant
A53T-Syn. Deletion of UBD or pharmacological inhibition of the proteasomes
abolishes the Herp-mediated stabilization of ER Ca2+ homeostasis. Furthermore,
knockdown or pharmacological inhibition of ER Ca2+ release channels ameliorates ER
stress suggesting that impaired homeostatic regulation of Ca 2+ channels promotes a
protracted ER stress with the consequent activation of ER stress-associated cell death
pathways. Interestingly, sustained upregulation of ER stress markers and aberrant
accumulation of ER Ca2+ release channels were detected in transgenic mutant A53TSyn mice. These data establish a causative link between impaired ER Ca2+
homeostasis and chronic ER stress in the degenerative cascades induced by mutant
A53T-Syn and suggest that Herp is essential for the resolution of ER stress through
maintenance of ER Ca2+ homeostasis.
Because oxidants and mitochondria-derived free radicals can target ER-based
Ca2+ regulatory proteins and cause uncontrolled Ca2+ release that may contribute to
protracted ER stress resulting in cell death, I next determined the impact of the PD
causing neurotoxin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), the precursor
of 1-methyl-4-phenylpyridinium (MPP+) on ER functions. I demonstrated that knockdown
of Herp renders dopaminergic cells vulnerable to MPP+-induced toxicity by a
mechanism involving upregulation of CCAAT/enhancer binding protein homologous
protein (CHOP) and depletion of the ER Ca2+ store. Conversely, ectopic expression of
Herp confers protection by blocking MPP+ -induced CHOP upregulation, ER Ca2+ store
depletion and mitochondrial Ca2+ accumulation in a manner dependent on a functional
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ubiquitin-proteasomal protein degradation pathway. Deletion of the UBD or treatment
with a proteasomal inhibitor abolished the central function of Herp in ER Ca 2+
homeostasis. Collectively, our findings suggest that approaches that aim to increase
Herp levels or its ER Ca2+-stabilizing action may prevent or ameliorate neuronal loss in
PD.
Though abnormal protein aggregates are characteristic features of the slowly
progressive neurodegenerative disorders, they are also found in acute pathological
states such as cerebral ischemia. The role of protein aggregation in neuronal pathology
after brain ischemia is not clear. In the last part of my work, I show that transient focal
ischemia induces the continuous accumulation of insoluble Syn and DJ-1, two proteins
linked to early-onset PD, in vulnerable neurons from the onset of reperfusion until delayed
neuronal death. Double immunocytochemical analysis reveals that Syn and DJ-1 are
co-localized in inclusion-like structures in the vulnerable neurons of the lesioned
cortices suggesting that DJ-1 is recruited into the Syn-containing inclusions and
thereby precludes this neuroprotective protein from exercising its anti-oxidant and
chaperone-like activities. Supporting this notion, knockdown of DJ-1 promotes Syn
insolubility and renders neurons vulnerable to an ischemic insult whereas ectopic
expression of DJ-1 ameliorates Syn -induced degenerative cascades and reverses
ischemic neuronal injury. Furthermore, mice deficient in Syn exhibit significantly
smaller infarcts and improved behavioral recovery after ischemia compared to nontransgenic mice. Ablation of Syn ameliorates the accumulation of insoluble DJ-1 and
the ensuing oxidative damage following an ischemic insult. Taken together, our data
show that aberrant accumulation of Syn plays a precipitating role in ischemic neuronal
v

injury and suggest that PD-causing mutations in Syn and DJ-1 can worsen ischemic
brain damage.
In conclusion, these studies provide insights into the molecular cascade of Syninduced degeneration and may uncover novel therapeutic strategies for PD and stroke.
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CHAPTER ONE: GENERAL INTRODUCTION
Part I
Being one of the most common debilitating neurodegenerative disorders,
Parkinson’s disease (PD) presents an enormous medical, social, financial and scientific
problem. PD is a progressive movement disorder that stems predominantly from the
degeneration of dopaminergic neurons (DA) in the substantia nigra pars compacta
(SNpc) (1). It is second only to Alzheimer’s disease as the most common ageassociated neurodegenerative disorder with an estimated incidence of 20/100,000 and
a prevalence of 150/100,000 (2). One main neuropathological hallmark of PD is the
presence of lewy bodies (LB) and lewy neurites in DA neurons (Figure 1). These are
intracellular aggregates of αSyn that were initially characterized by eosin staining (2, 3).

Figure 1-1. A mature lewy body in neuron of the substantia nigra pars compacta
(3)
Though PD has been known since ancient times, it was first described by James
Parkinson in 1817 in his detailed medical essay entitled, ‘An Essay of the Shaking
Palsy’. Clinical manifestations of PD include motor impairments such as resting tremor,
1

rigidity, bradykinesia, gait disturbances and postural instability. These result from the
inhibition of the nigrostriatal motor pathway due to loss of 70-80% of striatal dopamine
(4). While the motor symptoms of PD prevail the clinical picture and even define the
parkinsonism syndrome, many PD patients also experience non-motoric symptoms like
autonomic, cognitive and psychiatric problems (Table 1). To date, there is no known
prevention or cure for PD. Although the motor symptoms are treatable, the benefit of the
drugs frequently diminishes or become less consistent over time. A major hurdle in the
development of effective neuroprotective agents is the limited understanding of the
disease process leading to death of DA neurons.
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Table 1-1. Clinical Features of PD

The specific etiology of PD is incompletely understood, but it is believed that a
combination of genetic susceptibilities (Table 2) and environmental factors, herbicides
and pesticides, seem to play a critical role (6). While the majority of cases are sporadic,
epidemiological studies unveil that < 10% of PD has a strict familial etiology. The
discovery of at least 10 distinct genetic loci accountable for rare Mendelian forms of PD
(Table 2) have established the role of heredity in the development of PD and granted
imperative cues to understanding the molecular pathogenesis of the more common
sporadic forms of this disease (4). Studies on the genetics, epidemiology, and
3

neuropathology of PD, in addition to the development of new experimental models
revealed new concepts on disease mechanisms that are guiding researchers to develop
treatments to prevent neurodegeneration and halt the progressive course of PD.

Table 1-2. Several gene loci identified for PD

Animal and cell culture models are essential tools to identify disease
mechanisms, novel therapeutic targets, and assess potential therapies. Two
experimental models of PD include the engineered genetic model (Chapter 2) and the
neurotoxin model (Chapter 3).
1) The Neurotoxin Model. Among the neurotoxins, (1-methyl-4-phenyl-1,2,3,6tetrahydropyridine), MPTP, is the best studied and widely used to model
environmental cause of PD in non-human primates and rodents. MPTP is
lipid-soluble and readily penetrates the blood-brain barrier, BBB and brain
cells. MPTP is converted by monoamine oxidase B in astrocytes to the toxic
MPP+ which then enters the DA neurons via the dopamine transporter (DAT)
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and inhibits mitochondrial complex I resulting in ATP depletion, oxidative
injury and death of DA neurons (5, 6) (Figure 2).
2) Engineered models. Pathological αSyn is linked mechanistically to both
familial and sporadic PD. Therefore, to elucidate the pathophysiology of PD
various transgenic mice overexpressing the PD-linked mutant αSyn were
developed. As transgenic mice expressing mutant A53T αSyn exhibit more
severe effects than the other αSyn mutations, we employed the A53T αSyn
mice under the regulatory control of the prion promoter (7).These mice
develop severe movement disorder, paralysis and synucleinopathy and show
an extensive loss and degeneration in brainstem neurons and spinal cord
motor neurons. However, they do not completely recapitulate the disease
process as there was no evidence of DA degeneration in the substantia nigra
(8-12). However, Dr. Masliah’s Lab has developed a transgenic model that
exhibits DA neuronal loss. This was achieved by overexpressing αSyn under
the control of the platelet-derived growth factor–β (PDGF-β) promoter (12). In
addition, overexpression and knockout experiments of the other familial PD
genes in mice have also been created. These experimental animal models
have improved our understanding of disease development of the more
common sporadic form of PD.
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Figure 1-2. Schematic illustration of the mechanisms involved in toxicity of MPTP
The mechanisms responsible for the preferential degeneration of DA neurons in
PD have been debated for decades. The principal molecular pathways that commonly
underlie the pathogenesis of both sporadic and familial forms of PD are depicted in
(Figure 4). These include the production of free radicals and oxidative stress,
mitochondrial damage, dysfunction of the ubiquitin-proteasome system (UPS), aberrant
protein degradation and aggregation.

6

Recent studies have demonstrated hallmarks of endoplasmic reticulum (ER)
stress in experimental models of PD (13-16).The ER is an essential intracellular
organelle implicated in the regulation of intracellular Ca2+ homeostasis and in the folding
and processing of proteins. Conditions that compromise ER functions induce ER stress
(17, 18) (Figure 3). ER stress triggers the unfolded protein response (UPR) that
consists of a series of interconnected control mechanisms that diminish cell damage
caused from protein buildup in the ER (19-21). These include the attenuation of general
protein synthesis, the transcriptional activation of the genes encoding ER-resident
chaperones to relieve disturbances of the ER, and molecules involved in ER-associated
degradation (ERAD). ERAD functions in cellular ‘quality control’ and regulation of ERresident proteins, and is crucial for the disposal of accumulated unfolded proteins (22,
23). Severe and prolonged ER stress inevitably leads to cell death (17).
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Figure 1-3. ER stress elicits UPR, ERAD and Ca2+ signaling (24)
Though ER stress is closely associated with PD, it is yet not clear whether and
how ER stress contributes to the degenerative cascades in PD. Characteristic of UPR
have been demonstrated in several experimental models of PD (13-15). Particularly,
induction of mutant A53TαSyn in PC12 cells causes ER stress (15). Parkin, a protein
ubiquitin E3 ligase that is involved in the degradation of unfolded proteins is the most
commonly mutated gene known to result in familial PD (25, 26). Loss of function
mutations in parkin are implicated in abnormal protein degradation by the UPS thus
inducing ER stress (26, 27). Formation of LB together with the accumulation of
oxidatively damaged and aggregated proteins in the SNpc of sporadic PD patients are
indicative of aberrant proteolytic degradation (28). UPR is also upregulated in the
8

neurotoxin-induced cell death model of PD (13, 14, 29) suggesting that ER stress may
symbolize a common molecular pathway contributing to the neuronal degeneration in
familial and sporadic PD.
Cell fate after ER stress is believed to be regulated by the balance between proapoptotic and survival signals (30) (Figure 3). Important mediators of ER stressassociated cell death include activation of procaspase 12 (in mouse) or procaspase 4
(in human) and increased expression of the pro-apoptotic transcription factor
CCAAT/enhancer-binding protein homologous protein (CHOP) (31, 32). For instance,
the expression of mutant A53T PD-linked αSyn results in reduction of proteasomal
activity, elevation of CHOP and Grp78/Bip expression, induction of caspase-12
activation and ultimately in ER-mediated cell death (15). CHOP has been identified as a
critical mediator of apoptotic death in the SNpc dopamine neurons in an in vivo
neurotoxin model of PD (33) and in ischemic stroke (34). Its critical role in ER-stressinduced cell death has been demonstrated using CHOP knockout mice (34, 35).
Moreover, upregulation of ER stress proteins during the ER stress response is
important to restore ER homeostasis and enhance cell survival (Figure 3). Specifically,
Grp78/Bip a fundamental regulator of ER homeostasis owing to its copious functions in
protein folding, ER calcium binding, and controlling of the activation of the
transmembrane ER stress sensor; its induction during ER stress represents a
prosurvival arm of the UPR (36-38). Another positive regulator of ER stress is the
homocysteine-inducible ER stress protein (Herp), an ER membrane-bound, ubiquitinlike protein with both its N- and C- termini facing the cytoplasm (39, 40). Its N-terminal
contains a proteasome-interacting motif (PIM) (40, 41) and interacts with Hrd1, a
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membrane anchored E3 ligase (42). These findings have led to the supposition that
Herp may interact with the proteasome during UPR to facilitate ERAD and thus alleviate
ER stress. Studies have demonstrated that Herp expression is rapidly upregulated in
cultured primary neurons and astrocytes exposed to proteasomal inhibitors or
pharmacological agents that selectively induce ER dysfunction (43, 44). Increased Herp
transcripts were also observed in the peri-ischemic regions in rat brains after ischemic
stroke (44). Significantly, studies using Herp null cells revealed enhanced vulnerability
to ER stress-mediated cell death (44). Reduction of Herp expression by RNA
interference (RNAi) enhances susceptibility to ER stress-induced cell death whereas its
overexpression promotes neuronal survival (43). Herp has also been shown to preserve
ER Ca2+ homeostasis and mitochondrial function, and inhibits caspase-12 activation in
neuronal cells subjected to ER stress (43). Therefore, the ability of Herp to alleviate ER
stress and cellular death is suggested to be coupled with its capacity to stabilize cellular
Ca2+ homeostasis.
Several reports implicate deregulated ER Ca2+ release in the pathophysiology of
numerous neurodegenerative diseases including, Alzheimer’s, Huntington, and prion
disease as well as acute disorders such as stroke (16, 45-47). Yet, very little is known
about the ER Ca2+ homeostatic response during ER stress and whether its
dysregulation leads to sustained ER stress and activation of ER stress-mediated cell
death pathways. As the major intracellular Ca2+ store, the ER controls several vital
neuronal activities such as transmitter release, gene transcription and synaptic plasticity
(46, 48, 49). It contains two main types of Ca2+ release channels, the inositol 1,4,5triphosphate receptors (IP3R) and the ryanodine receptors (RyR). RyRs are stimulated
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to release further Ca2+ by Ca2+ itself, a process termed Ca2+-induced Ca2+ release
(CICR) (46, 50, 51). The IP3R’s on the other hand are activated by the second
messenger IP3. Large increases in the expression of IP3R are reported to accompany
apoptosis in several cell types (50, 51). Several lines of evidence suggest that the
increased level of RyR is associated with enhanced Ca2+ response to the RyR agonist
caffeine (52-54) and increased neuronal vulnerability to excitotoxic and oxidative insults
(52, 53, 55). Both prion (PrP106-126) and Aβ peptides enhance oxidative stress,
caspase 12 activation, and apoptotic cells death by a mechanism that involves the
exaggerated ER Ca2+ release through IP3R and RYR (45, 52, 56, 57). Ca2+ release
from the ER also appears instrumental in ischemic cell injury and trauma (47). Thus, the
importance of ER Ca2+ release and its central involvement in ER stress-associated cell
death is demonstrated in studies showing that blockers of IP3Rs and RyR can protect
neurons against cell death induced by glutamate excitotoxicity, Aβ and prion peptides
(52, 56, 58). Uncontrolled Ca2+ release from the ER via RyR and IP3R may also be
involved in the pathogenesis of PD, but a detailed mechanism of their contribution is yet
to be determined (Chapter 2).
ER stress increases ER Ca2+ fluxes that can activate apoptosis via mitochondrial
dependent and/or independent mechanisms (32, 59). Ca2+ released from the ER could
activate caspase 12 but may also function as a positive amplifying loop for the
mitochodrial-dependent apoptotic pathway (60, 61). A plethora of studies have
established that loss of ER Ca2+ and concomitant Ca2+ uptake by mitochodria can lead
to the collapse of mitochondria membrane potential, opening of mitochodrial transition
pore and release of proapoptotic factors (62-64). Ca2+ uptake by mitochondira leads to

11

increased reactive oxygen species (ROS) production which instigate a vicious postivie
feed back cycle involving ROS-induced deregulated Ca2+ release from ER stores,
destabilization of mitochodrial Ca2+ handling and more ROS generation (62). ROS has
been shown to directly modulate the gating or RyR (65) and IP3R (66) suggesting that
oxidative stress can facilitate RyR and IP3R-induced apoptosis (66) in which
deregulated Ca2+ release leads to increased mitochondrial Ca2+ loading. Hence,
disruption of ER Ca2+ homeostasis is a common denominator of pathological processes
resulting in neuronal injury in various neurodegenerative diseases.
To date, dopamine replacment therapy using (L-DOPA) is the most prowerful
treatment for PD, however, it is not a cure nor it can halt the progerssion of this
disorder. Additional efforts are still required in order to further characterize the common
mechanisms involved in the demise of dopaminergic neurons both in the sporadic and
the genetic forms of PD. This will ultimatly provide vital advances in our understanding
of the disease and will broaden our horizon in better designing targeted and more
specific therapies.
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Figure 1-4. Schematic
neurodegeneration in PD

representation

13

of

the

mechanisms

involved

in

Part II
Ischemic stroke is the commonest acute neurodegenerative disease; it
represents 87% of all strokes (67) (Figure 5). It is considered to be the third leading
cause of death in the US after diseases of the heart and cancers in addition to being the
second worldwide (68-70). To convey the gravity and the burden that this disease
imposes on society, the AHA estimated that 6 400 000 Americans over the age of 20
years have already experienced a stroke, and that approximately 795 000 people each
year have a stroke (69, 70). Stroke causes substantial morbidity and mortality, the AHA
group states that on average someone dies of a stroke every 4 minutes and that
someone in the US has a stroke every 40 seconds (AHA computation based on latest
available data). The total costs of stroke are colossal and it was estimated that 73.7
billions of dollars were spent in 2010 (69, 70), unfortunately, we still have limitations in
stroke therapy.

Ischemic Stroke
Hemorrhagic Stroke

Figure 1-5. Causes of Stroke: > 80% are ischemic and ~20% are hemorrhagic
As in PD, the incidence of stroke also increases with aging. The prevalence of
stroke is higher in women as it represents an important health concern especially for
postmenopausal women; however, its incidence seems to be the reverse, whereby
14

younger men are at higher risks than younger females (68-70). Situations like,
hypertension, high cholesterol, diabetes, obesity and cigarette smoke as well as
decreased physical activity predominantly play a causative role and increases the risks
for stroke episode (68, 70). It has been known for decades that genetics is a
contributing element and thus play a role as a risk factor for stroke. To this end, an
elegant genome wide association studies published in the New England journal of
medicine identified two genes, namely WNK1 and NINJ2 that may be strongly
implicated in ischemic stroke (71). Wnk1 is a large cytoplasmic serine-threonine kinase,
expressed in the developing nervous system, kidneys and heart (72, 73). Being an ion
homeostasis regulator (74), mutations in Wnk1 have been associated with familial
hyperkalemic hypertension (75) and the severity in hypertension (73, 76, 77) further
suggesting its implication in ischemic stroke. Ninj 2 is a homophilic cell adhesion
molecule (78), also known as “nerve-injury-induced protein” as its name clearly states it;
Ninj2 plays a role in nerve regeneration and neurite outgrowth (78). A recent study
further shows the link between polymorphism in Ninj2 and its association with ischemia
in a Chinese Han population (79, 80) this further supports the notion and confirms that
genetic variations influence the risks of stroke.
Ischemic stroke occurs when a blood vessel supplying blood to the brain is
obstructed as shown in (Figure 6).
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Figure 1-6. Types of stroke

Immediately following ischemia synaptic transmission is disrupted, glutamate
accumulates at synapses, resulting in overactivation and desensitization of its receptors
that can eventually be neurotoxic (81, 82). Glutamate is the major excitatory
neurotransmitter in the mammalian central nervous system (CNS) (83). This amino acid
is implicated in several neuronal processes such as neural development, excitatory
synaptic transmission and plasticity (83-85). Glutamate activates three classes of
ionophore-linked postsynaptic receptors, namely, N-methyl-D-aspartate (NMDA), αamino-3-hydroxy-5methyl-4-isoxazole propionic acid (AMPA) and Kainate receptors
(83). NMDA receptor-mediated toxicity is dependent on Ca2+ entry directly through this
receptor-gated ion channel (81, 86). As most AMPA receptor channels have poor Ca 2+
permeability neuronal injury may result primarily from indirect Ca2+ entry through voltage
–gated Ca2+ channels (87), or Ca2+ permeable acid sensing ion channels (88). The
combination of ischemia reperfusion I/R and Ca2+ overload trigger several downstream
16

lethal reactions including nitrosative and oxidative stress and mitochondrial dysfunction
(81, 89), as summarized in (Figure 7). Furthermore, a plethora of transcription factors
(TFs) are activated immediately after an ischemic insult. These TFs have been shown
to contribute in the post-ischemic inflammation and ischemic neuronal death (90, 91),
specifically, the transcription factor p53 (92). Though, p53 is best known for its tumor
suppression functions (93), it also plays a key role in I/R induced cell death (92, 94).
Consistent with this notion, pharmacological inhibition of p53 improved neuronal survival
after ischemic injury (95). As noted, the overstimulation of glutamate receptors trigger
intracellular event that induces neuronal death after ischemic stroke. Thus, synaptic
glutamate receptor channels have been considered as a promising target for stroke
therapy (96). Alas, all clinical stroke trials targeting glutamate receptors (AMPA or
NMDA) have failed, conceivably because these receptor antagonists interfere with the
physiological functions of glutamate as well (97, 98).
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Figure 1-7. Schematic diagram summarizing glutamate excitotoxicity in ischemic
neuronal degeneration
Stroke has been classified as an epidemiologic risk factor for Alzheimer’s
disease and may play a pivotal role in the initiation or acceleration process of
neurodegenerative events (99). Yet, whether ischemia is implicated in increasing the
risk of developing PD is still questionable. Like in PD, protein aggregation is also a
feature of acute neurodegenerative disease. Abnormal buildup of protein aggregates
18

also develops post ischemic stroke and has been detected in vulnerable neurons from
the onset of I/R until delayed neuronal death (100, 101). Both the nature and the role of
the protein aggregates found in ischemic brains have not been established yet. Several
studies support the critical role of oxidative and nitrative stress in neuronal demise after
I/R and demonstrate that oxidation modified proteins accumulate and participate in the
generation of protein aggregates (102, 103).
αSyn accumulates in neurons with age (104); moreover, its toxicity is generally
considered a consequence of its aggregation (25). αSyn is the first gene discovered
whose mutations cause autosomal dominant forms of familial PD (105) (Table 2). It is a
small 140 amino acid abundant synaptic protein whose physiological functions are still
being deciphered. αSyn is a natively unfolded protein that becomes structured upon
binding to lipid membranes (106, 107). It is thought to play a role in regulating synaptic
plasticity, vesicle release and trafficking (108, 109). Cell culture studies have shown that
overexpression, impaired turnover and mutations lead to αSyn aggregation, block the
activity of the ubiquitin-proteasomal system (UPS) and ultimately to neuronal cell death
(110, 111) (Figure 4). Biochemical studies have shown that αSyn forms amyloid fibrils
and that all three missense mutations in αSyn accelerate the aggregation of the protein
(112, 113). Furthermore, exposure to oxidizing conditions, specifically nitration of αSyn
has been shown to increase its propensity to aggregate (11). Of much greater
significance is the finding that overexpression of wild-type αSyn also causes autosomaldominant PD demonstrating that abnormal accumulation of the normal αSyn protein is
sufficient to cause disease (114). At higher doses, αSyn is deleterious to neurons and
this has further been confirmed in a study showing that MPTP treatment increases αSyn
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expression and hastens dopaminergic neuronal death (115). Conversely, αSyn

-/-

mice

are resistant to MPTP-induced toxicity (116). Furthermore, the endangering
consequences of αSyn following traumatic brain injury were also prevented in αSyn

-/-

mice (117). Hence, αSyn accumulation and aggregation has proven to be associated in
the pathological cascades leading to neuronal loss in both acute and chronic
neurodegenerative disorders.
DJ-1 is another PD gene linked to early onset disease with autosomal recessive
inheritance (118) (Table 2). DJ-1 is a small 189 amino acid protein (119) that is
profusely found in most mammalian tissues, including the brain, where it is localized to
both neurons and glia (120). The physiological function of DJ-1 remains mostly
unknown although many lines of evidence suggest that DJ-1 may function as an antioxidant protein or as a sensor of oxidative stress (121). DJ-1 oxidizes itself to remove
hydrogen peroxide in vitro, suggesting that it may function in part as a direct scavenger
of ROS (121, 122). Other proposed functions include transcriptional co-activator and
chaperone activity (123, 124). Its noticeable antioxidant activity emerges from the ability
of DJ-1 to stabilize Nrf2 (nuclear factor erythroid 2-related factor), a key transcriptional
regulator of the oxidant response (123). DJ-1 also functions as a redox-regulated
chaperone to inhibit aggregation and toxicity of αSyn during oxidative stress (124).
Moreover, eleven different mutations have been found in the DJ-1 gene (118, 125), of
which the L166P and C106A missense mutations (126) shown to cause loss of function
and exacerbate neuronal death under stress conditions (118, 127). Consistent with this
notion, DJ-1 knockdown cells and DJ-1

-/-

mice or flies are exceedingly susceptible to

PD-inducing neurotoxins such as, MPTP, paraquat, rotenone, and 6-hydroxydopamine
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(128-130). DJ-1

-/-

mice also display larger infarcts post I/R as compared to their wild-

type counterparts (131); however, its overexpression in vivo confers neuroprotection
against I/R induced injury (132) (Figure 8).
Several studies point to the interaction between DJ-1 and αSyn and its
pathological accumulation in brain tissues from PD patients (133), in in vitro settings
(134) as well as other related disorders such as Alzheimer’s disease, Pick’s Disease
and corticobasal degeneration (135). Reduced DJ-1 solubility has been verified in PD
brain tissues and thereby hinders it from performing its cellular anti-oxidant responses
(133). Supporting this notion, DJ-1 has been shown to translocate to mitochondria
where it plays a role in maintaining mitochondrial integrity (128, 136). Loss of DJ-1
function renders mitochondria more sensitive to oxidative stress and aggravates ROS
production (129). This in part, results in the activation of redox-regulated TFs, p53
(137). Under normal conditions, p53 exists in the cells at very low levels, but its
expression rapidly increases in response to diverse insults including oxidative stress
and DNA damage (138). The Jun N-terminal kinase 1/2 (JNK1/2) is known to be
activated by oxidative stress and increases p53 stability by phosphorylation (139). P53
propagates death responses to oxidative stress and has been shown play a pivotal role
in I/R induced cell death (92, 94, 95, 138). Its importance has been shown in both PD
and ischemic models whereby DJ-1 deficiency leads to the activation of the p53
pathway (95, 137). P53-/- mice or treatments with pifithrin-α, a p53 inhibitor renders
neurons more resistant to MPTP toxicity (140, 141). Furthermore, chemical inhibition of
p53 has been shown rescue vulnerable neurons from ischemic insults both in vivo and
in vitro (95, 138). Parkin, another PD-associated gene (Table 2) has also been shown
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to play a role in neuronal degeneration post ischemic injury (142). I/R contribute to the
reduction of parkin protein which results in the accumulation and aggregation of
ubiquitylated proteins and thus enhancing vulnerability to ER-stress induced cell death.
Recently, it has been shown that parkin alleviates αSyn-induced neuronal cell death in
animal and cell culture models (143). These findings suggest a functional relationship
between these PD-associated proteins.

Figure 1-8. DJ-1 reduces infarct size after Ischemia-reperfusion
(A) Intrastriatally injected rats with Glutathione S-transferase tagged DJ-1, GST-DJ-1
(132). (B) DJ-1 wild-type (WT), HET (heterozygous), KO (knockout) mice (131).
In conclusion, the development of effective neuroprotective therapies is of
paramount importance. Over the years, a great number of animal and cellular models
have been developed to mimic human stroke. These models have helped scientists
understand the complexity of the pathological mechanisms involved in ischemic injury.
Despite all these efforts, we still do not have a preventative remedy for stroke. It is
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noteworthy to point that the mechanisms involved in neuronal death in stroke and
chronic

neurodegenerative

diseases

are

usually

investigated

independently.

Consequently, it is of imperative endeavor to thoroughly decipher the overlapping
interrelated

pathophysiological

processes

associated

with

chronic

and

acute

neurodegenerative disease to help develop powerful and successful therapies.
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CHAPTER TWO: THE HOMOCYSTEINE-INDUCIBLE ENDOPLASMIC RETICULUM
(ER) STRESS PROTEIN HERP COUNTERACTS MUTANT Α-SYNUCLEIN-INDUCED
ER STRESS VIA HOMEOSTATIC REGULATION OF ER-RESIDENT CALCIUM
RELREASE CHANNEL PROTEINS
Human Molecular Genetics (IN PRESS), published by Oxford University Press

Introduction
Parkinson’s disease (PD) is a progressive neurodegenerative movement disorder
that results from the degeneration of dopaminergic (DA) neurons in the substantia nigra
(1). A common pathological feature of PD is the aggregation of -synuclein (Syn) into
cytoplasmic inclusions called Lewy bodies in the degenerating dopaminergic neurons
(1). Cell culture studies have shown that overexpression, impaired turnover, and
mutations lead to Syn aggregation (2). Two missense mutations (Ala53Thr and
Ala30Pro) in Syn that cause early-onset, autosomal dominant forms of PD enhance
the aggregation and toxicity of the protein (2). Duplication or triplication of the Syn
gene was also found to cause early onset PD suggesting that elevated levels of wildtype Syn can also lead to neurotoxicity (3). It is not yet clear how Syn aggregation
induces the degenerative cascades leading to PD.
Recent studies have demonstrated that mutant Syn may exert its pathological
effects in parts by inactivating the Grp78/Bip chaperone function (4) or impeding
endoplasmic reticulum (ER) to Golgi vesicular transport (5) leading to abnormal
accumulation of proteins within the ER and induction of ER stress. Cells respond to ER
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stress by activating the unfolded protein response (UPR) aimed at inducing translational
repression and expression of ER-resident chaperones to enhance protein folding,
processing and degradation of misfolded proteins, thus relieving cells from ER stress
(6). Prolonged or unmitigated ER stress associated with insufficient degradation of
misfolded proteins or deranged Ca2+ homeostasis would subsequently activate ER
stress-associated apoptotic pathways (7).
Hallmarks of ER stress are detected in several experimental models of PD (8, 9)
and in nigral dopaminergic neurons of PD subjects (10). Expression of PD-linked mutant
Syn elevates CCAAT/enhancer binding protein (C/EBP) homologous protein (CHOP)
(11), an ER stress-induced apoptotic mediator (12). CHOP is also elevated in
neurotoxin models of PD (8, 9) and is a critical mediator of apoptotic death in substantia
nigra dopamine neurons (13). Salubrinal, a neuroprotective agent that acts to inhibit ER
stress protects cells from death induced by overexpression of mutant Syn (11).
Furthermore, ER stress is closely associated with the aggregation of Syn in
dopaminergic neurons (10). Though these studies suggest that ER stress is of
pathophysiological relevance in PD, the underlying mechanisms of ER stress-mediated
degenerative cascades and the specific roles of the various UPR proteins in PD
pathogenesis remain unknown.
Herp (Homocysteine-inducible ER stress protein) is an ER integral membrane
protein with the N-terminal ubiquitin-like domain projecting into the cytosol (14).
Upregulation of Herp is essential for neuronal survival as Herp knockdown enhances
vulnerability to ER stress-induced apoptosis (15, 16). How Herp contributes to the
restoration of ER homeostasis remains unclear. Herp appears to stabilize ER Ca 2+
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homeostasis and mitochondrial function in neural cells subjected to ER stress (16).
Herp may also play an essential role in ER-associated protein degradation (ERAD), the
primary mechanism of misfolded protein degradation, as its knockdown results in the
selective accumulation of ERAD substrates (17). Recent studies demonstrated that
Herp is induced in PD substantia nigra and is present in the core of Lewy bodies (18).
The roles of Herp in PD remain unknown. Because Herp was shown to be critical for
survival adaptation in the neurotoxin models of PD (19), we investigated whether Herp
may counteract the neurodegenerative cascades caused by induced expression of
mutant Syn. We found that Herp plays an essential role in suppressing mutant Syninduced activation of ER stress-associated apoptosis signaling by inhibiting the
deregulated ER Ca2+ release associated with the aberrant accumulation of ER resident
Ca2+ release channels.

Materials and Methods
Cells, Plasmid and Reagents
Pheochromocytoma 12 (PC12) and human embryonic kidney 293 (HEK293) cells
were purchased from ATTC. PC12 cells were selected because they are dopaminergic
and have been extensively studied as models of neuronal degeneration. The pcDNA3.1
plasmids containing the c-myc-tagged full-length or loss-of-function deletion of human
Herp cDNA have been described previously (16, 19). Xestospongin C (Tocris),
dantrolene (Sigma), bradykinin (Sigma) were prepared as concentrated 1000x stocks in
dimethylsulfoxide (DMSO; Sigma) or Lock’s solution (mM): NaCl, 154; KCl, 5.6; CaCl2,
2.3; MgCl2, 1.0; NaHCO3, 3.6; glucose, 10; Hepes buffer, 5 (pH 7.2). Salubrinal was
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purchased from Santa Cruz. The dose of each drug was selected based on previously
published studies (11, 20). Caffeine (Sigma) was freshly prepared in water. Additional
reagents included: Lipofectamine 2000, TRIzol, Opti-MEM, priopidium iodide, and
protein A beads (Invitrogen), MG-132 (BioMol), Trypan blue solution (0.4%; VWR), and
tunicamycin (Sigma).

Cell Culture, Transduction, and Electroporations
PC12 and HEK293 cells were maintained in a humidified 5% CO2 and 95% air
atmosphere at 37 °C in Dulbecco's Modified Eagle Medium (DMEM) high glucose
medium supplemented with 10% heat-inactivated horse serum, 5% heat-inactivated
fetal bovine serum, 50 units/ml penicillin, and 0.05 mg/ml streptomycin (16, 20). PC12
cell lines expressing the human wild-type and mutant Syn were generated using a
tetracycline (Tet)-on system. For the induction of Syn expression, culture medium was
replaced every other day with DMEM containing 1% horse and 0.5% fetal bovine sera
(InVitrogen), 100 ng/ml nerve growth factor (Upstate) and Tet (2 µM; Sigma). In some
studies, non-induced clones were transduced with recombinant adeno-associated viral
(rAAV) particles prior to induction with Tet. Transient transfection was carried out using
the Neon transfection system according to the manufacture’s instructions (Invitrogen).
PC12 cells (1-2 x 107/ ml) were transfected by electroporation with 4-8 µg of empty
vector, wild-type Syn, or mutant Syn (gift from Dr. R.G. Perez, Department of
Neurology, University of Pittsburgh) using the following optimized conditions: 1400 V, 20
ms and 1 pulse. The transfection efficiency following electroporation with wild-type
Syn-GFP was ~70%.
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Ectopic Expression of Herp
The Herp and UBL-Herp constructs have been inserted into a rAAV expression
construct (GenDetect). The resulting cDNAs were cloned into the HindIII/BamHI site of
the pAd-YC2 shuttle vector. For homologous recombination, the shuttle vector (5 µg)
and rescue vector pJM17 (5 µg) were co-transfected into HEK293 cells. To amplify the
recombinants, cell culture supernantant was serially diluted into serum-free media and
incubated with HEK293 cells. The recombinants were purified from supernatants by
ultracentrifugation. The band containing mature viral particles were collected and
desalted against phosphate-buffered saline (PBS) in a Vivaspin column (Vivascience
AG), and titers were determined by counting the number of plaques. Cells were infected
with the virus at a MOI of 500 in medium containing 2% FBS for 4 h, after which DMEM
containing 10% FBS was added. Analysis of rAAV-GFP expression indicated an
infection rate of ~85-90%.

Experimental Treatments
To induce ER stress, cultures of PC12 cells were treated with 20 g/ml Tuni. In
some studies, the proteasomal inhibitor MG-132 (0.1-10 M) or salubrinal (75 μM) were
added prior to Tuni. These drugs were prepared in DMSO immediately before applying
them to the cultures. When DMSO was used as the solvent, their final concentration did
not exceed 0.1%. At the end of each treatment, the cultures were processed for
immunoblotting and evaluating cell viability.
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RNA interference (RNAi)
Cells were transfected with Mission predesigned siRNA duplexes (Sigma)
targeting Herp, IP3R1, RYR1, and RYR3, or a control siRNA (siRNA-Con; Ambion)
using Lipofectamine 2000 (Invitrogen) in Opti-MEM according to manufacturer's
protocol. The target sequences of each siRNA are listed in Supplemental Tables 1S.
Results of quantitative RT-PCR analysis of total RNA from PC12 cells and tissue
samples revealed expression of IP3R2, IP3R3 and RYR2 below the limit of detection of
the qRT-PCR assay method (Ct values >35). The optimized siRNA concentrations are
100 nM of siRNA-Herp, 250 nM of siRNA- IP3R1, and 100 nM of each siRNA-RYR1
and siRNA-RYR3 added in combination. After 4 h of transfection, the medium was
replaced, and 24-48 h later, the indicated experiments were conducted. To monitor
knockdown, cells were harvested and processed for qRT-PCR and Western blot
analyses. The transfection efficiency of siRNA-Con-FITC (Santa Cruz) in PC12 cells
was greater than 95% (data not shown).

Assessment of Cell Death
Cell death was assessed by either trypan blue exclusion or propidium iodide
staining as described previously (16, 20). Trypan blue and propidium iodide (50 μg/ml)
stain only the cells with disrupted plasma membrane integrity so these cells were
considered dead. The PI was excited with the 568-nm yellow line of a confocal
microscope (Leica), and the acquisition of PI labeling images was performed at the
wavelength higher than 600 nm via a photomultiplier through a band-pass filter centered
at 605 nm. Dead cells were counted in four microscopic fields per dish, with a minimum
of 100 cells per field and results were expressed as a percentage of the total number of
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cells. All of the experiments were repeated at least three times without knowledge of
treatment history.

Immunoprecipitation
Cells and tissues were solubilized in binding buffer containing 50 mM Tris–HCl
(pH 7.4), 150 mM NaCl, 1 mM EDTA, 1 mM DTT, 0.2 mM phenylmethanesulfonyl
fluoride, and 1.0% NP-40 as described previously (21). The homogenate was
centrifuged at 20,000 × g for 10 min. Solubilized proteins were adjusted to 0.1% NP-40
and incubated for 12 h at 4 °C with a polyclonal antibody to anti-Herp (BioMol), IP3R1
(Millipore) or pan-RyR (Santa Cruz). After an additional incubation with protein A
conjugated beads, the immune complexes were then recovered by low speed
centrifugation and washed extensively with the binding buffer containing 0.1% NP-40.
Immunoprecipitated proteins were eluted by boiling in SDS-PAGE sampling buffer and
analyzed by immunoblotting.

Immunoblotting
Protein lysates were centrifuged at 20,000 g and equal amounts of the proteins
were loaded into each well of a SDS-PAGE. After electrophoretic separation and
transfer to nitrocellulose membranes (Bio-rad), blots were incubated in blocking solution
(5% milk in TBS-T) for 1 h at RT, followed by an overnight incubation with primary the
following antibodies diluted in blocking buffer: -Syn [human specific antibody (Abcam)
or cross-reactive with human, rat, and mouse (Santa Cruz)], KDEL (Santa Cruz), actin
(Sigma), ERK1 (Cell Signaling), caspase-12 (Abcam), Herp [polyclonal antibody
(Biomol) and monoconal antibody (Santa Cruz)], CHOP (Abcam), IP3R1 (Millipore),
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pan-RyR (Santa Cruz), S5a (Cell Signaling) and presenilin 1 (Abcam). Membranes were
then incubated for 1 h in secondary antibody conjugated to horseradish peroxidase
(HRP), and bands were visualized by enhanced chemiluminescence (ECL, ThermoScientific). Membranes were stripped and re-probed with either the actin or ERK1
antibody to normalize protein loading. The intensity of the signals obtained was
quantified by densitometric scanning using Scion (NIH Image).

Immunostaining
Spinal cords were removed after perfusion with heparinized saline (0.9% NaCl)
transcardially followed by 4% buffered paraformaldehyde (PFA) and post-fixed
overnight in PFA. Serial sections of the lumbar region were sectioned at 30 µm with a
freezing microtome (Microm HM 505 N) and collected on slides. Cultured cells plated on
coverslips were fixed for 20 min with 4% paraformaldehyde in PBS following
experimental treatments. Cells were then incubated for 5 min in a solution of 0.2%
Triton X-100 in PBS and for 1 h in blocking solution (0.02% Triton X-100, 5% normal
horse or goat serum in PBS). Tissue sections and coverslips were processed for
immunofluorescence staining as described (16, 21) with the following primary
antibodies: Syn (Abcam), nitro-Syn (Abcam), Herp (Santa Cruz); CHOP (Cell
Signaling); KDEL (Santa Cruz); pan-RyR (Santa Cruz), IP3R1 (Millipore), and NeuN
(Millipore). All antibodies were diluted in blocking solution and used within the
concentration ranges recommended by the manufacturer. To test for nonspecific
staining by the secondary antibodies, additional sections or coverslips were processed
in a similar fashion without the primary antibodies or with adsorbed antibodies. After
three washes, sections or coverslips were incubated with fluorescein isothiocyanate
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(FITC)-conjugated anti-rabbit and Cy3-conjugated anti-mouse secondary antibodies and
then mounted. To stain the nuclei, sections or coverslips were further incubated with the
nucleic acid stain 4',6-diamidino-2-phenylindole (DAPI) in PBS containing 1% RNase
and 0.2% Triton X-100 for 10 min, and then mounted in FluorSave aqueous mounting
medium (Calbiochem). Immunofluorescence staining was examined by using a NIKON
80i fluorescent microscope equipped with a x60 oil immersion objective lens. For
quantification, digitized images of immunostained sections were obtained with Qimaging
Retiga 2000 SVGA FAST 1394 cooled digital camera system mounted on the
microscope and then analyzed with IP lab software (BD Biosciences- Bio-imaging).
Total area of pixel intensity was measured with the automated measurement tools in IP
lab software. The total density was averaged and expressed as normalized, corrected
values.

Measurement of [Ca2+]i
PC12 cells were plated at a density of 1x10 6 cells / 35mm glass bottom MatTek
dish (Ashland) the day before the experiment. Cells were loaded with 2 μM Fura-2
acetoxymethyl ester in Krebs–Ringer-Hepes (KRH) buffer [129mM NaCl, 5mM
NaHCO3, 4.8mM KCl, 1.2mM KH2PO4, 1mM CaCl2, 1.2mM MgCl2, 10 mM glucose and
10mM Hepes (pH7.4)], for 20 minutes and then washed twice with KRH and incubated
for additional 30 minutes at 37°C. Dishes were placed into a heated chamber mounted
on the stage of an inverted fluorescence microscope (Nikon Eclipse TiE with perfect
focus and DG-5 Xenon excitation) and perfused with Ca2+-deficient KRH at a rate of 1.5
ml/ minute. Baseline was established for 6 minutes before stimulation. Measurements
were continued for 4-5 min after Ca2+ peak was recorded. Fura-2 dual excitation images
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were captured through a Nikon S Fluor 20X objective (NA 0.75) with a Photometrics
QuantEM 16bit EMCCD camera using 340 nm and 380 nm excitation filters and a 470550nm emission filter. Data were acquired and analyzed using Nikon Elements
software. Background fluorescence signals were collected at the same rate for the
same wavelengths and were subtracted from the corresponding fluorescence images.
The fluorescence intensities of 10-20 cells / dish were expressed as ratio of excitation
340/380 nm and area under the curve (AUC).

RT-PCR and Quantitative Real Time-PCR (qRT-PCR)
Total RNA was isolated with TRIzol (Invitrogen). To prevent genomic DNA
contamination, the isolated total RNA samples were treated with DNAse. 2 μg of total
RNA was reverse transcribed with Superscript II reverse transcriptase and an oligo(dT)
primer (Invitrogen). RT-PCR products were resolved on agorose gels stained with
ethidium bromide. Relative quantification of gene expression was performed by
normalizing the fluorescence intensities of each band to those of actin. qRT-PCR was
performed as previously described (22). The integrity of the RT-PCR products was
confirmed by melting curve analysis. Melting curves for all reaction showed one specific
peak. We used 18 S rRNA as an endogenous control to normalize variations in RNA
extraction and variability in RT efficiency. mRNA levels were quantified with the
comparative Ct method (22). The pairs of primers used for RT-PCR and qRT-PCR are
listed in Supplemental Tables 2 and 3, respectively.
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Animals
Mice transgenic for human A53T-Syn (THY1-SNCA-A53T; Jackson) have been
characterized in a previous study (30). All animal experimental procedures were
performed in accordance with the guidelines of the NIH and approved by the
Institutional Animal Care and Use Committee at University of Central Florida.

Statistical analysis
Comparison between two groups was performed using Student's t test, whereas
multiple comparisons between more than two groups was analyzed by one-way ANOVA
and post hoc tests by least significant difference. Data evaluated for the effects of two
variables was analyzed using two-way ANOVA (Prism 4 version 4.03; GraphPad
Software, Inc.). Results are presented as means ± SEM. For all analyses, statistical
significance is defined as a p value of ≤ 0.05.

Supplementary Methods
Calcium imaging
PC12 cells were plated on 35-mm glass bottom dishes (Matek) and loaded with 4
µM Fluo-4 acetoxymethyl ester (Invitrogen) in Lock’s buffer at 37 C for 30 min. The
cells were then washed twice with and incubated in Lock’s buffer for an additional 30
min, and then mounted on the stage of an inverted confocal microscope (Carl Zeiss)
equipped with a 40× objective. To trigger ER Ca2+ release, 10 µM bradykinin was added
directly to the cell solution. Cells were excited using the 488-nm laser line, and images
were acquired at 5-s intervals under time-lapse mode.
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Immunoprecipitation
Cell lysates and tissue homogenates were incubated with an antibody to Herp
(BioMol), c-myc (Sigma), S5a (Cell Signaling), IP3R1 (Millipore), pan-RyR (Santa Cruz)
or Syn (Abcam and Santa Cruz) antibody in binding buffer containing 50 mM Tris–HCl
(pH 7.4), 150 mM NaCl, 1 mM EDTA, 1 mM DTT, 0.2 mM phenylmethanesulfonyl
fluoride, and 1.0% NP-40. Antigen-antibody complexes were precipitated with
immobilized protein A, washed three times in immunoprecipitation buffer, and
solubilized by heating in Laemmli buffer containing 2-mercaptoethanol at 100 °C for 4
min. The solubilized proteins were separated by electrophoresis and analyzed by
immunoblotting.

Results
Expression of Mutant Syn Evokes a Sustained ER Stress Response
Previous studies provide evidence that mutant Syn triggers a cell death
program that involves activation of the ER stress response (11). It is yet not clear which
and how ER stress proteins contribute to mutant Syn-induced cell death. To
investigate the role of Herp in the mutant Syn-induced degenerative process, we
generated Tet-inducible PC12 cells. Time course analysis indicated that Syn protein
level reaches a plateau 48 h after induction (Fig. 1A). Concurrently, mRNA and protein
levels of the ER stress markers Grp78 and Herp were markedly elevated in the PC12
cells expressing mutant Syn, especially those expressing A53TSyn (PC12A53TSyn), when compared to PC12 cells expressing wild-type Syn (PC12-WTSyn)
(Fig. 1B). Levels of CHOP were also markedly higher in PC12-A53TSyn (Fig. 1B)
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suggesting, that at this expression level, there was a selective deleterious effect of
A53TSyn but not WTSyn. Similar results were obtained in PC12 cells transiently
expressing A53TSyn and WTSyn (Fig. 1C).

Herp Protects Against Mutant Syn-Induced Cell Death
Compared to PC12 cells stably expressing the empty vector (PC12-VT), PC12WTSyn and PC12-A30PSyn, PC12-A53TSyn exhibits significantly higher baseline
cell death (Fig. 2A) which correlated with increased CHOP protein level and caspase12 activation (Fig. 2B). Because A53TSyn enhances activation of ER stress-related
apoptosis signaling, we utilized PC12-A53TSyn in subsequent knockdown studies.
PC12-A53TSyn treated with a small interference RNA (siRNA) targeting Herp (siRNAHerp) but not a non-silencing control siRNA (siRNA-Con) exhibited higher basal rate of
cell death (Fig. 2C). In contrast, ectopic expression of Herp, but not the dominantnegative mutant UBL-Herp that lacks the UBL domain (Fig 2D), significantly improved
the viability of PC12-A53TSyn (Fig. 2E). Notably, UBL-Herp appeared to potentiate
A53TSyn-induced cell death consistent with a dominant-negative action of UBL-Herp
as reported previously (19).

Mutant Syn Perturbs ER Ca2+ Homeostasis During ER Stress
Given that Herp protects from A53TSyn-induced death (Figs 2C, E) and that
Herp plays a crucial role in stabilizing ER Ca2+ homeostasis in ER-stressed PC12 cells
(16), we next determined whether A53T-Syn may perturb ER Ca2+ regulation by
altering the activity of the two main classes of ER-resident Ca2+ release channels, IP3R
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(inositol triphosphate receptor) and RYR (ryanodine receptor) which can be activated by
their respective agonists, bradykinin and caffeine (20-22). The average peak amplitude
of bradykinin-evoked Ca2+ release in the absence of extracellular Ca2+ was significantly
larger in PC12-A53TSyn when compared to PC12-WTSyn and PC12-VT (Fig 3A)
indicating that A53TSyn enhances ER Ca2+ release. No significant difference was
observed in thapsigargin-induced depletion of ER Ca2+ store (Supplementary Fig 1A)
suggesting that the ER stress–induced perturbation of intracellular Ca2+ level ([Ca2+]i) in
PC12-A53TSyn cannot be explained by higher ER lumenal Ca 2+ but rather is caused
by a higher fraction of ER Ca2+ being released via IP3R.
Tunicamycin (Tuni) is a classical ER stressor that induces a sustained increase
of ER stress proteins (Supplementary Fig 1B, C). The magnitude of the bradykininevoked Ca2+ release was also higher in PC12 cells treated with Tuni (PC12-Tuni) when
compared to control cells that were left untreated or treated with vehicle (data not
shown; 16,19). Consequently, treatment with BAPTA-AM, a cell permeable Ca2+
chelator, markedly improves the viability of both PC12-A53TSyn and PC12-Tuni (Fig
3B) suggesting that Tuni and A53TSyn increase susceptibility to ER stress-induced
death by enhancing ER Ca2+ release.

Mutant Syn-Induced ER Stress Perturbs Homeostatic Regulation of ER-Resident
Ca2+ Release Channels
Next, we determined whether the heightened cytosolic Ca 2+ level in PC12-Tuni
and PC12-A53TSyn results from altered homeostatic regulation of ER-resident Ca2+
release channels. Three distinct types of

IP3Rs (types 1–3) have been cloned in

mammals and each type shows distinct properties in terms of their IP 3 sensitivity,
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modulation by cytoplasmic Ca2+ concentration, and unique tissue distribution (23,24).
Among them, the type 1 IP3R (IP3R1) is highly expressed in the central nervous system
(24). qRT-PCR analysis showed that IP3R1 is the major IP3R isoform expressed in
PC12 cells (unpublished data). PC12 cells also express RYR1 and RYR3 (pan-RyR)
(20, 21). Levels of IP3R2, IP3R3, and RYR2 mRNAs were not assessed due to their low
abundance in PC12 cells. PC12-Tuni exhibit marked accumulation of IP3R1 and panRyR protein (Fig 3D; Suppl Fig 1C) consistent with the notion that Tuni-induced ER
stress leads to disruption of ER Ca2+ homeostasis (16). Expression of A53TSyn also
induces a marked increase in the protein levels of IP 3R1 (Fig 3E) and pan-RyR (Fig 3F)
suggesting that the aberrant accumulation of ER Ca2+ release channels was likely
mediated through a common ER stress-related mechanism. Consistent with the
elevated pan-RYR protein levels, PC12-Tuni and PC12-A53TSyn were more
vulnerable to cell death in the presence of caffeine when compared to their respective
controls (Supplementary Fig 1D). By contrast, level of presenilin1 (PS1) which
functions as a passive ER Ca2+ leak channel (25), was not markedly altered by ER
stress (Fig 3D, E). It is worth noting that unlike the increase of ER stress proteins which
is mediated by a transcriptional mechanism (6, 7), the ER stress-associated
accumulation of IP3R1 and pan-RYR was independent of transcription (Supplementary
Fig 1E,F).

Inhibition of Deregulated ER Ca2+ Release Ameliorates ER Stress-Mediated Cell
Death and Syn Aggregation
Because ER-released cytosolic Ca2+ plays a critical role in the activation of
several death effector pathways (16), we next determined whether blockade of ER Ca 2+
50

release may ameliorate ER stress-induced cell death. Xestospongin C (a blocker of
IP3R) and dantrolene (a RyR blocker) at doses that did not cause robust death within 24
h substantially improved the viability of PC12-Tuni (Fig 4A) and PC12-A53TSyn (Fig
4B). Neither IP3R nor RyR inhibition altered the expression of Syn (data not shown),
thereby confirming that inhibition of ER Ca2+ release rather than reduced expression of
A53T-Syn contributes to cell protection.
To further determine whether these ER-resident Ca2+ release channels are
responsible for the heightened sensitivity of PC12-A53TSyn to ER stress-mediated cell
death, we knocked down each channel protein at a time by using either siRNA-IP3R1 or
siRNA-RYR1 and siRNA-RYR3 in combination (Fig 4C). The non-silencing control
siRNA (siRNA-Con) alone did not alter IP3R1 nor RYR1/RYR3 expression (not shown).
A close correlation between protein levels of these ER Ca 2+ release channels and the
ER stress-induced apoptotic mediator CHOP (Supplementary Fig 2) was observed in
PC12-Tuni (Fig. 4D) and PC12-A53TSyn (Fig 4E). CHOP which is known to be
upregulated following a severe or prolonged ER stress, was markedly suppressed along
with Herp and Grp94/78 in PC12-Tuni transfected with the silencing siRNAs
(Supplementary Fig 2). These data suggest that impaired homeostatic regulation of
ER-resident Ca2+ release channels might underlie chronic activation of ER stress and
associated apoptosis signaling.
Because ER-released cytosolic Ca2+ plays a role in promoting Syn aggregation
(26), we next examined Syn inclusion formation in PC12 cells transiently transfected
with either WTSyn or A53TSyn tagged to green fluorescent protein (GFP) by
fluorescence microscopy. Xestospongin C substantially reduces not only the fraction of
51

cells bearing cytoplasmic Syn inclusions but also the size of the inclusions
(Supplementary Fig 3). These fluorescent aggregates were not detected in PC12 cells
transfected with GFP alone (data not shown).

Salubrinal Inhibits ER Stress-mediated Cell Death by Preventing the Aberrant
Accumulation of ER-Resident Ca2+ Release Channels
Next, we asked the question whether salubrinal, a compound that has been
shown to ameliorate A53TSyn-induced cell death (11), may counteract prolonged ER
stress through the homeostatic regulation of ER-resident Ca2+ release channels.
Salubrinal at a dose that inhibits the cellular phosphatase complexes that
dephosphorylate eiF2 (Supplementary Fig 4) not only blocks the ER stressassociated increase of IP3R and pan-RYR but also dramatically reduces protein levels
of Herp, Grp94/78 and CHOP in both PC12-Tuni (Fig 5A) and PC12- A53TSyn (Fig
5B) suggesting that this compound likely ameliorates ER stress by improving the
homeostatic regulation of ER Ca2+ release channels through a mechanism that is
independent of transcription (Fig 5C). By contrast, salubrinal did not alter PS1 protein
level in PC12-Tuni (Fig 5A) and PC12-A53TSyn (Fig 5B). The salubrinal-mediated
decrease of ER Ca2+ release channels was accompanied by a substantial reduction in
the bradykinin-evoked Ca2+ transients in both PC12-Tuni (Supplementary Fig 5A) and
PC12-A53TSyn (Supplementary Fig 5B). Consequently, salubrinal also significantly
ameliorates the Ca2+ dependent aggregation of A53TSyn-GFP in the cytosol
(Supplementary Fig 3).
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Herp Counteracts ER Stress Through the Homeostatic Regulation of ER-Resident
Ca2+ Release Channels
Because Herp counteracts Tuni-induced cell death through the stabilization of
ER Ca2+ homeostasis (16), we next determined whether Herp protects PC12-A53TSyn
(Fig 2C, D) by a similar mechanism. Knockdown of Herp substantially increases the
amplitude of the bradykinin (BK)- induced Ca2+ transients (Fig 6A) that result from the
marked accumulation of IP3R1 (Fig 6B; Supplementary Fig 6A). Levels of pan-RYR
but not PS1 proteins were also affected by Herp knockdown (Fig 6B; Supplementary
Fig 6A). Consequently, the deficits in Herp-dependent homeostatic regulation of ER
Ca2+ release channels is also accompanied by increased levels of the ER stress
markers Grp94/78 and CHOP (Fig 6B; Supplementary Fig 6A) and enhanced
vulnerability to Syn-induced death (Fig 6C). Conversely, ectopic expression of Herp
suppresses the aberrant accumulation of IP3R1 and pan-RYR but not PS1 proteins (Fig
6D; Supplementary Fig 6B). Neither knockdown nor ectopic expression of Herp alters
mRNA levels of IP3R1 and pan-RYR (Supplementary Fig 6C, D) suggesting that,
analogously to salubrinal, Herp promotes the homeostatic regulation of these ERresident Ca2+ release channels through a mechanism that is independent of
transcription.
Knockdown of Herp also increases basal (Fig 6E, F) and stress-induced
accumulation (Fig 6E, G) of both IP3R1 and pan-RYR proteins independently of
transcription (Fig 6H) in PC12-Tuni. Consistent with the notion that Herp counteracts
Tuni-induced death (19), knockdown of Herp results in a significant increase of CHOP
protein by transcriptional regulation (Fig 6 E, H).
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Herp Promotes Degradation of ER-Resident Ca2+ Release Channels Through
ERAD
Because Herp has been shown to bind to and target protein substrates for ERAD
(17), we next tested whether Herp modulates the levels of IP3R1 and/or pan-RYR
proteins by a similar mechanism. Immunoprecipitation with an anti-Herp antibody
followed by immunoblotting with antibodies to each ER Ca2+ release channel
demonstrated that a greater fraction of Herp forms a complex with IP 3R1 and pan-RYR
in PC12-Tuni when compared to vehicle-treated control cells (Fig 7A). The specificity of
the interaction was confirmed by immunoblotting the Herp-containing protein complex
with an antibody to Grp78 (Supplementary Fig 7A) and by performing the coimmunoprecipitation assay using lysates from HEK293 expressing c-myc-tagged Herp
(Supplementary Fig 7B). Neither the pre-immune normal IgG nor Grp78 antibody
forms a protein complex with Herp. Double immunofluorescence labeling confirmed
Herp colocalization with each ER Ca2+ release channel protein in PC12-Tuni
(Supplementary Fig 7C). Herp also interacts with A53TSyn (Supplementary Fig 7D,
E) suggesting that this interaction could possibly interfere with the protective role of
Herp (see discussion).
To determine whether binding of Herp to IP3R1 and pan-RYR results in
proteasome-mediated protein degradation of these Ca2+ release channel proteins,
PC12 cells were treated with the proteasome inhibitor MG-132. Consistent with the
notion that the degradation of IP3R1 and pan-RYR proteins is mediated by the
proteasomes (27, 28), MG-132 markedly increases steady-state protein levels of these
ER-resident Ca2+ release channels (Fig 7B; Supplementary Fig 8A). Ectopic
expression of Herp results in a significant reduction of IP 3R1 and pan-RYR protein
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levels (Fig 7C) that can be reversed upon inhibition of proteasome activity (Fig 7D,
Supplementary Fig 8B). Note that MG-132 also increases Herp protein levels (Fig 7B,
D) suggesting that Herp itself is a proteasome substrate (29). In support for this notion,
Herp interacts and co-localizes with the ubiquitin-interacting S5a subunit of the
proteasome in PC12-Tuni (Supplementary Fig 9A, B). Increased co-localization of S5a
with the Grp78-labeled ER was also detected in PC12 cells transfected with Herp
(Suppl Fig 9B). Though S5a protein level was not markedly altered in PC12-Tuni
(Supplementary Fig 9C), knockdown of Herp substantially reduces S5a co-localization
with the ER in PC12-Tuni suggesting that ER stress-induced upregulation of Herp but
not S5a is sufficient for the recruitment of proteasomes to the ER (Supplementary Fig
9D). Collectively, our data indicate that aberrant accumulation of IP3R and pan-RYR
perturbs ER Ca2+ homeostasis in ER stressed cells and that Herp prevents aberrant ER
Ca2+ release by targeting these ER-resident Ca2+ release channels for ERAD.

Accumulation of ER Stress Markers and ER-Resident Ca2+ Channels in A53TSyn
Transgenic Mice
Next, we explored whether A53TSyn-induced ER stress markers and ER Ca2+
channels were detected in vivo. Transgenic mice overexpressing A53TSyn (A53T
mice) develop motor abnormalities associated with the accumulation of Syn inclusions
in spinal cord motor neurons (30). Immunoblotting reveals marked upregulation of Herp
and Grp78/Bip proteins in spinal cords of 8 months old A53T mice (symptomatic)
when compared to 2 months old A53T mice (pre-symptomatic) and non-transgenic
(Non-Tg) mice (Fig 8A, B). CHOP protein was low in Non-Tg mice but was readily
detected in A53T mice (Fig 8A, B).

Immunohistochemistry indicates
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a marked

increase of nitrated Syn in NeuN-labeled spinal cord neurons and further confirms the
increase of ER stress markers and ER-resident Ca2+ release channels in 13-15 months
old (symptomatic) when compared to 5 months old (pre-symptomatic) A53T mice
(Supplementary Fig 10 A). By contrast to the ER stress markers, the upregulation of
ER-resident Ca2+ release channels was not attributed to increased expression
(Supplementary Fig 10 B). The amounts of IP3R1 and pan-RYR in the spinal cord
homogenates that form a protein complex with Herp were also markedly higher in A53T
compared to Non-Tg mice (Fig 8C) consistent with the notion that ERAD may contribute
to the homeostatic regulation of ER Ca2+ release channel proteins in spinal cord motor
neurons. The interaction between Herp and A53TSyn was also confirmed in spinal
cords of symptomatic transgenic mice (Supplementary Fig 10 C) suggesting that this
interaction may impair the ability of Herp to prevent the aberrant accumulation of ERresident Ca2+ release channels and, hence,

its ER Ca2+ -stabilizing action in ER

stressed motor neurons. These findings link aberrant ER Ca2+ regulation and chronic
ER stress to motor neuron dysfunction and death in the pathophysiology of
synucleinopathies.

Discussion
Neuronal loss in both familial and sporadic forms of neurodegenerative disorders
is accompanied by formation of protein inclusions or fibrillar aggregates composed of
misfolded proteins that can induce ER stress. The accumulation of evidence that ER
stress is critically involved in the pathogenesis of neurodegenerative disorders suggests
that approaches that aim to halt ER stress may prevent the pathological cascades
induced by protein inclusions. There is growing evidence that the ER can play pivotal
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roles in regulating cell survival and apoptosis in a variety of cell types including neurons
(30, 31), but the mechanisms linking ER stress to apoptosis are incompletely
understood. The identification of conditions that slow ER stress may reveal novel
strategies for counteracting ER stress-mediated cell death.
The ER is the major intracellular store of Ca2+ and aberrant regulation of luminal
ER Ca2+ is thought to play critical roles in many apoptotic cascades (31). Deregulated
ER Ca2+ homeostasis has also been implicated in the pathophysiology of chronic
neurodegenerative diseases such as prion disorders, Huntington’s and Alzheimer’s (3234).

Here we showed that A53TSyn evokes ER stress and that the attendant

disturbances in ER Ca2+ homeostasis contributes to a higher sensitivity to ER stressinduced cell death. We demonstrate that Herp counteracts A53TSyn-induced cell
death by stabilizing ER Ca2+ homeostasis.

Ectopic expression of Herp markedly

reduced A53TSyn-induced toxicity whereas knockdown of Herp exacerbates or
prolongs ER stress leading to a significant augmentation of toxicity. Hence, a better
understanding of the function of Herp is therefore of high significance to elucidate the
functional link between the ER stress and ER Ca2+ homeostasis and to develop
mechanism-based neuroprotective strategies for PD and related neurodegenerative
diseases.
The underlying molecular mechanism(s) whereby Herp modulates ER Ca 2+
homeostasis remains poorly understood. Knockdown of Herp leads to the accumulation
of IP3R1 and pan-RyR proteins in PC12 cells and, consequently, promotes aberrant ER
Ca2+ release that in turn may decrease the threshold for the activation of ER stressrelated cell death pathways. Consistent with this notion, gene knockdown and
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pharmacological inhibition of ER Ca2+ release channels ameliorates ER stress and
protects PC12- A53TSyn and PC12-Tuni against ER stress-induced cell death (Fig 4).
Conversely, overexpression of Herp stabilizes ER Ca2+ homeostasis and inhibits ER
stress-induced cell death by preventing the accumulation of ER Ca 2+ release channel
proteins in PC12-A53TSyn. It is noteworthy that the accumulation of IP3R1 and panRyR proteins was partially suppressed in spite of the elevated level of endogenous Herp
in PC12-A53TSyn suggesting that binding of Herp to A53TSyn (Supplementary Fig
7D) and its accumulation in the core of Lewy bodies (18) may interfere with its
protective function and that ectopically expressed Herp can overcome this A53TSynmediated inhibition.
Mechanistically, Herp interacts with and facilitates the degradation of ER Ca 2+
release channel proteins by ERAD. Several recent studies support a role for Herp in
ERAD (17) based on the notion that Herp is rapidly degraded in a proteasomedependent fashion (29) and that knockdown of Herp leads to the accumulation of
several established ERAD substrates (17). Herp has been shown to interact with Hrd1p,
a membrane-anchored E3 ligase that is required for ERAD (17), and with ubiquilin, a
shuttle protein that delivers ubiquitinated substrates to the proteasome for degradation
(35). We found that Herp knockdown in ER stressed cells leads to the accumulation of
both IP3R1 and pan-RYR. Conversely, ectopic expression of Herp prevents the
accumulation of these ER Ca2+ release channels. Treatment with MG-132 not only
elevates the basal level of IP3R1 and pan-RYR proteins but also prevents the ability of
Herp to inhibit their accumulation in ER stressed cells (Fig 7D) suggesting the critical
involvement of ERAD in the homeostatic regulation of these ER Ca2+ release channels.
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Deletion and function analyses further support the involvement of ERAD in Herpmediated cell protection via the stabilization of ER Ca2+ homeostasis. Ectopic
expression of Herp lacking the UBL-domain which functions as a proteasomeinteracting domain (17, 43) fails not only to stabilize ER Ca2+ homeostasis but also to
protect PC12-Tuni (16) and PC12-A53TSyn from ER stress-induced death (Fig 2E).
Notably, salubrinal appears to modulate the vulnerability of PC12 cells to ER stressinduced cell death by preventing the accumulation of ER Ca 2+ channels (Fig 6). How
this eIF2α dephosphorylation inhibitor impacts the homeostatic regulation of ER Ca2+
channels remains to be investigated.
Our data provide the first evidence that ER stress is regulated by the activity of
ER-resident Ca2+ release channels. We found that pharmacological inhibition or
knockdown of ER Ca2+ release proteins ameliorates ER stress-induced cell death
suggesting that aberrant ER Ca2+ release is associated with higher susceptibility to
chronic enhancement of ER stress. Though the detailed mechanisms underlying Ca 2+dependent cell death in PC12-A53TSyn was not investigated in the present study, it is
likely that accumulation of ER Ca2+ release channels leads to enhanced ER to
mitochondria Ca2+ flow that triggers the loss of mitochondrial membrane potential and
increased generation of reactive oxygen species (ROS) (16). Previous studies
demonstrate that ROS-induced damage to the ER may amplify Ca2+ release via a
mechanism involving oxidation-induced activation of RYR and IP3R (36). Ectopic
expression of Herp has been shown to counteract this deleterious positive feedback
loop by inhibiting the proapoptotic Ca2+ flow from the ER to mitochondria in PC12 cells
exposed to the PD-inducing toxin 1-methyl-4-phenylpyridinium (MPP+) (19). The
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increase of CHOP detected in PC12-Tuni, PC12-A53TSyn and siRNA-Herp treated
PC12 cells likely results from the depletion of ER Ca 2+ store associated with the
aberrant accumulation of IP3R1 and pan-RYR as ectopic expression of Herp
counteracts CHOP upregulation by promoting the homeostatic regulation of these ER
Ca2+ channel proteins.
It is noteworthy that chronic enhancement of ER stress resulting from the
disruption of ER Ca2+ homeostasis could trigger Syn protein aggregation in the cytosol
and that blockade of ER Ca2+ release channels (Supplementary Fig 2) ameliorates
Syn inclusion formation suggesting a causative link between chronic ER stress and
Syn oligomer formation. Consistent with this notion, sustained ER Ca 2+ release
triggered by thapsigargin accelerates the formation of potentially cytotoxic oligomers in
Syn-GFP transfected cells (26). Tuni at doses that induce chronic stress associated
with sustained ER Ca2+ release (16, 37) has also been shown to promote the
accumulation of Syn oligomers (38). Because Sal ameliorates ER stress and protects
PC12- Tuni and PC12-A53TSyn, it is conceivable that its neuroprotective action may
be due to improved regulation of ER Ca2+ homeostasis. In support of this notion, Sal
inhibits the aberrant accumulation of ER-resident Ca2+ release channels (Fig 6) and
prevents Syn aggregation (Supplementary Fig 5).
Consistent with the findings in PC12-A53T cells, we detected higher levels of
several ER stress markers including the ER stress-induced apoptotic mediator CHOP,
and ER-resident Ca2+ release channels in the spinal cords of symptomatic A53T mice
when compared to Non-Tg and pre-symptomatic A53T mice suggesting that
accumulation of A53TSyn promotes motor neuron degeneration in part by a
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mechanism involving chronic ER stress associated with the deregulation of ER Ca 2+
homeostasis. In addition to the elevation of Herp protein, we detected increased
interaction of Herp with A53TSyn in spinal cord homogenates of symptomatic A53T
mice which further supports the notion that Herp-dependent ERAD of ER-resident Ca2+
release channels may be impaired in vulnerable motor neurons.
Dopaminergic neurons appear to be relatively resistant to degeneration in A53T
mice (30, 39) and express relatively high levels of the Ca2+-binding protein calbindin
(39). By contrast, spinal cord motor neurons are characterized by low cytosolic Ca 2+
buffering capacities (40) and, hence, may be more susceptible to chronic ER stress
induced by A53TSyn and associated degenerative processes triggered by the aberrant
ER Ca2+ release. Future studies will determine whether direct modulation of Herp
expression in vivo may impact the levels of ER-resident Ca2+ release channel proteins,
Syn inclusion formation, disease manifestations and progression. Because ER stress
elicited by the aggregation of amyotrophic lateral sclerosis-linked mutant superoxide
dismutase 1 (SOD1) has been implicated in motor neuron death (41) and because
salubrinal delays the disease process and extends the lifespan of mutant G93A-SOD1
mice (42), elucidation of the cellular and molecular mechanisms that promote or prevent
disturbances in ER Ca2+ homeostasis may lead to novel approaches for therapeutic
intervention for synucleinopathies and motor neuron diseases.
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Figures

Figure 2-1. Expression of mutant Syn induces a heightened ER stress response
(A) A representative immunoblot showing the time course of wild-type (WT) human
Syn protein level after the addition of Tet. The antibody used was specific for human
Syn. (B) Representative gel images (top) and immunoblots (bottom) of WT and mutant
(A30P and A53T) Syn, Herp, Grp94/78, and CHOP mRNA and protein levels,
respectively, in PC12 cells 72 h after the addition of Tet (induced) or vehicle (non-
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induced). PCR products amplified were separated on ethidium bromide stained agarose
gels. Blots were reprobed with ERK1 to confirm equality of total protein loading. (C)
Representative immunoblots (top) and results of densitometric analysis (bottom) of
Herp, Grp94/78, and CHOP protein levels in PC12 cells at the indicated time points
following transient transfection with either WT or mutant (A53T) Syn. Control cells
were transfected with the empty vector (VT). The antibody used was specific for human
Syn. Values are the mean ± SEM of three independent experiments. #p<0.05; *p<0.01,
compared to PC12-VT and PC12-WT-Syn and between the indicated groups.

Figure 2-2. Herp protects from mutant Syn-induced cell death
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(A) Trypan blue exclusion was used to determine the viability of the indicated PC12
clones at 96 h under induced or non-induced conditions. Data represent the mean ±
SEM of three separate experiments. #p<0.05,*p<0.01, compared to PC12-WTSyn and
PC12-VT under non-induced and induced conditions; *p<0.01, between the indicated
clones expressing mutant Syn. (B) Representative immunoblots of protein levels of
Syn and CHOP and caspase-12 (Casp12) processing in the indicated PC12 cells 72 h
after the addition of Tet (induced) or vehicle (non-induced). Appearance of the active
proteolytic fragment of Casp12 is indicated by an asterisk. ERK is used as an internal
control of protein loading. Histogram shows densitometric analysis of CHOP protein.
#

P<0.05, versus the PC12-WTSyn and PC12-VT under non-induced and induced

conditions; (C) Histograms show the viability of the PC12-A53T after transfection with
siRNA-Con and siRNA-Herp (100 nM). One day after transfection, Tet was added to the
cultures and cell viability was determined 48 h after by trypan blue exclusion. Values
represent the mean ± SEM of three separate experiments. #p<0.05, *p<0.01 compared
to respective non-induced and between the indicated induced PC12 cells. (D)
Representative immunoblots of Syn, Herp and UBL-Herp protein levels in the
indicated PC12 cells under non-induced (-) or induced (+) conditions for 48 h. PC12
cells were transduced with viral particles expressing empty vector or vector containing
Herp or UBL-Herp construct 48 h prior to induction. ERK is used as an internal control
of protein loading. (E) Histograms show the viability of the indicated PC12 cells after
ectopic expression of Herp and UBL-Herp. Trypan blue exclusion was used to
determine cell viability 48 and 96 h after induction. Values represent the mean ± SEM of
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three separate experiments. #p<0.05, *p<0.01, compared to groups transduced with the
empty vector or Herp and between the indicated transduced groups.
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Figure 2-3. ER stress-induced by tunicamycin and mutant -Syn perturbs ER Ca2+
homeostasis through the aberrant accumulation of ER-resident Ca2+ release
channels
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(A) Representative recordings of the bradykinin (BK; 10 μM)-induced elevation of
intracellular Ca2+ ([Ca2+]i) in PC12 cells 48 h after expression of wild-type (WT) and
mutant (A53T) Syn. PC12 cells transfected with empty vector (VT) were included as
controls. Cells were loaded with fura-2 and [Ca2+]i was recorded in Ca2+ free medium
as described under “Materials and Methods”. Arrow indicates time of BK addition.
Histograms show Ca2+ peak values (change from baseline) and AUC (area under the
curve). Values are the mean ± SEM of determinations made in 4 to 6 separate cultures
(15-20 cells assessed/culture). #p<0.05, compared to VT. (B) Histograms show the
percent of viable cells after treatment of PC12-Tuni (top) and PC12-A53TSyn (bottom)
with the indicated doses of BAPTA-AM. PC12 cells were pretreated with BAPTA-AM 2 h
prior to either exposure to Tuni (20 μg/mL) or expression of VT, WT and A53T. Cell
viability was determined 24 h after by Trypan blue exclusion. Values represent the
mean ± SEM of three separate experiments. *p<0.01, #p<0.05, compared to vehicle or
VT at each time point and between the indicated groups. (C) Representative
immunoblots (left) and results of densitometric analyses (right) of IP3R1, pan-RYR and
PS1 protein levels in PC12-Tuni at the indicated time points. Values represent the mean
± SEM of three independent experiments. *p<0.01, #p<0.05 compared to the untreated
group. (D) Representative immunoblots (left) and results of densitometric analyses
(right) of -Syn, IP3R1 and PS1 protein levels in PC12 cells at the indicated time points
after expression of VT, WT or A53T. Values represent the mean ± SEM of three
separate experiments.

#

p<0.05, *p< 0.01, compared to VT and WTSyn. (E) A

representative immunoblot (top) and results of densitometric analysis (bottom) of panRYR protein in PC12 cells at the indicated time points after expression of VT, WT or
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A53T.

The Tuni-treated samples were included as positive controls for ER stress-

induced increase of pan-RyR protein level. *p<0.01, compared to VT and WT. Equal
protein loading in the immunoblots shown in C-E was confirmed after reprobing the
membranes for actin.

Figure 2-4. Pharmacological inhibition or gene knockdown of ER-resident Ca2+
release channels ameliorates ER stress-induced cell death
(A) Histograms show the percent of viable PC12 cells after treatment with tunicamycin
(Tuni; 20 g/ml) (+) or vehicle (-) for 24 h in the absence or presence of the indicated
doses of xestospongin C (an IP3R blocker) or dantrolene (a RyR blocker). Both drugs
were added 2 h prior to Tuni. Values are the mean ± SEM of three independent
experiments. #p<0.05; *p< 0.01, compared to vehicle control and between the indicated
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groups. (B) Histograms show the percent of viable PC12 cells expressing empty vector
(VT), wild-type (WT) and mutant (A53T) -Syn. Xestospongin C (5 µM) or dantrolene
(50 µM) were added 24 h after induction. Values are the mean ± SEM of three
independent experiments. #p<0.05; *p< 0.01, compared to VT and WT-Syn and
between the indicated groups. (C) Histograms show the fold change of the indicated ER
Ca2+ release channel, IP3R1 (top) or RYR1/RYR3 (bottom), in PC12 cells 24 h after
transfection with the respective siRNAs (left panels) and the percent of viable
transfected PC12 cells at the indicated time points after exposure to Tuni or vehicle
(Con) (right panels). The siRNAs were added either 8 or 24 h (denoted by asterisk) prior
to Tuni exposure. Values represent the mean ± SEM of three independent experiments.
#

p<0.05;*p< 0.01, compared to Con and between the indicated groups. (D) Histograms

show the viability of the indicated PC12 cells in the presence of siRNA-IP3R1 (top) or
siRNA-RYR1 and siRNA-RYR3 combined (bottom). Values represent the mean ± SEM
of three independent experiments. #p<0.05; *p<0.01, compared to siRNA-Con.
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Figure 2-5. Salubrinal ameloriates the induction of ER stress markers and levels
of ER-resident Ca2+ release channels
(A) Representative immunoblots (top) and results of densitometric analysis (bottom) of
the indicated protein levels in PC12 cells that were treated with Salubrinal (Sal; 75 M)
for 2 h prior to exposure to tunicamycin (Tuni; 20 g/ml). Cells were collected at the
indicated time points for immunoblotting. Values represent the mean ± SEM of three
independent experiments. *p<0.01, compared between the indicated groups. (B)
Representative immunoblots (top) and results of densitometric analysis (bottom) of the
indicated protein levels in PC12 cells expressing empty vector (VT), wild-type (WT) or
mutant (A53T) Syn after treatment with Sal (+) or vehicle alone (-). Cells were
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collected 24 h after Sal treatment. Values represent the mean ± SEM of three
independent experiments. *p<0.01, compared between the indicated groups. (C) qRTPCR analysis of the relative expression of the indicated ER Ca 2+ release channels in
PC12 cells that were treated with Sal for 2 h prior to exposure to Tuni for the indicated
time points.
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Figure 2-6. Herp stabilizes Ca2+ homeostasis by preventing ER stress-induced
accumulation of ER-resident Ca2+ release channels
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(A) Representative recordings of the bradykinin (BK)-evoked increase of intracellular
Ca2+ ([Ca2+]i) in PC12 cells expressing mutant (A53T) Syn 24 h after transfection
with siRNA-Con or siRNA-Herp (100 nM). Arrow indicates the time of BK addition. Cells
were loaded with fura-2 and [Ca2+]i was recorded in Ca2+ free medium as described
under “Materials and Methods”. Histograms show Ca2+ peak values (change from
baseline) and AUC (area under the curve). Values are the mean ± SEM of
determinations made in 4 to 6 separate cultures (15-20 cells assessed/culture).
^p<0.001, compared to siRNA-Con.

(B) Representative immunoblots of ER stress

proteins and Ca2+ release channels in PC12 cells expressing VT, WT or A53T 24 h
after transfection with siRNA-Con and siRNA-Herp (100 nM). Asterisk indicates the
protein band corresponding to pan-RYR. The level of actin is not affected by siRNA
treatment. (C) Histograms showing the viability of PC12 cells expressing VT, WT or
A53T 24 h after transfection with siRNA-Con or siRNA-Herp (100 nM). Values represent
the mean ± SEM of three independent experiments. #p<0.05; *p<0.01, compared to the
siRNA-Con treated groups. (D) Representative immunoblots of levels of ER stress
proteins and Ca2+ release channels in PC12 cells expressing VT, WT or A53T after
transfection with empty vector (-) or vector expressing Herp (+) for 48 h. Asterisk
indicates the protein band corresponding to pan-RYR. (E-G) Representative
immunoblots and results of densitometric analysis of the indicated protein levels in
PC12 cells that were either transfected with the indicated siRNAs and collected 24 h
after (Basal condition; left panels) or transfected with the siRNAs 8 h prior to incubation
with tunicamycin (Tuni; 20 g/ml)) for 24 h (ER stress condition; right panels). *p<0.01,
compared to the siRNA-Con treated groups. (H) qRT-PCR analysis of the relative
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expression of the indicated proteins in PC12 cells that were treated with vehicle control
(Con), Tuni (20 g/ml) or siRNA-Herp (100 nM) for 24 h. Values represent the mean ±
SEM of three independent experiments. The mRNA level in Con was set at 1. *p<0.01,
compared to Con.

Figure 2-7. Herp interacts with and facilitates proteasomal-mediated degradation
of ER-resident Ca2+ release channels
(A) Representative immunoblots of the indicated ER Ca2+ release channels
immunoprecipitated (IP) by anti-Herp antibody from lysates of PC12 that were treated
with either tunicamycin (Tuni; 20 g/ml) or vehicle for 16 h. The pre-immune normal
IgG used as the negative control failed to yield an immunopositive band for IP3R or
RYR.

Input verifies the presence of these ER Ca2+ release channel protein in cell

lysates. (B) Representative immunoblots of Herp, IP3R1 and pan-RYR protein levels in
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PC12 cells that were treated with the indicated doses of the proteasomal inhibitor MG132 for 3, 6, 12, and 24 h. (C) Representative immunoblots of Herp and IP3R1 protein
levels in HEK293 cells that were transiently transfected with the indicated
concentrations of an empty plasmid (Vector) or a plasmid expressing Herp for 24 and
48 h. pan-RYR was undetectable in HEK293 cells. (D) Representative immunoblots of
Herp, IP3R, and pan-RYR protein levels in PC12 cells that were transfected with either
an empty plasmid (Vector) or a plasmid expressing Herp 24 h prior to the addition of 1
M MG-132. Cells were collected at the indicated time points after MG-132 addition.

Figure 2-8. Elevation of ER stress markers and ER-resident Ca2+ release channels
in A53T Syn mice
(A, B) Representative immunoblots (A) and results of densitometric analysis (B) of the
indicated ER stress proteins in lumbar spinal cords from age-matched non-transgenic
(Non-Tg) and mutant Syn (A53T) mice. A representative immunoblot confirming the
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expression of human Syn in spinal cords of A53T is shown (upper panel). All
immunoblots were reprobed for actin to control for equal protein loading (bottom
panels). Values represent the mean ± SEM of four mice per group. #p<0.05; *p<0.01,
compared to Non-Tg mice. (C) Immunoprecipitation to quantify protein levels of IP3R1
(top) and pan-RYR (bottom) in lumbar spinal cords of 8 months-old Non-Tg and A53T
mice. Each ER Ca2+ release channel protein was immunoprecipitated (IP) and
immunoblotted (IB) with the respective antibodies. Pre-immune normal IgG was used as
a negative control for IP. Histograms show the densitometric analysis of the band
corresponding to each ER Ca2+ release channel protein. Values represent the mean ±
SEM of four mice per group.*p< 0.01 compared to Non-Tg mice. (D) Representative
immunoblots of IP3R1 (left) and pan-RYR (right) in protein complexes IP with anti-Herp
antibody from lumbar spinal cord homogenates of 8 months-old Non-Tg and A53T mice.
Pre-immune normal IgG was used as a negative control for IP. Asterisk denotes the
specific band.
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Supplementary Figure 2-1. Effects of tunicamycin and mutant αSyn on ER luminal
Ca2+ levels, ER stress protein expression and cell survival
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(A) Representative recordings of the thapsigargin (Thap; 1 μM)-induced elevation of
intracellular Ca2+ ([Ca2+]i) in PC12 cells expressing wild-type (WT) or mutant (A53T) Syn. PC12 cells transfected with empty vector (VT) were included as controls. Arrow
indicates time of Thap addition. Cells were loaded with fura-2 and [Ca2+]i was recorded
in Ca2+ free medium as described under “Materials and Methods”. Histograms show
Ca2+ peak values (change from baseline) and AUC (area under the curve). Values are
the mean ± SEM of determinations made in 4 to 6 separate cultures (15-20 cells
assessed/culture). (B) Representative immunoblots (top) and results of densitometric
analysis (bottom) showing time course of Herp, Grp94, Grp78 and CHOP protein levels
in PC12 cells treated with either tunicamycin (Tuni; 20 g/ml) (+) or vehicle alone (-).
Values represent the mean ± SEM of three independent experiments. #p<0.05; *p<
0.01, compared to vehicle. (C) Representative immunoblots (top) and results of
densitometric analysis (bottom) of IP3R1, pan-RYR, and PS1 protein levels in PC12
cells at the indicated time points after the addition of Tuni (+) or vehicle alone (-).
Values represent the mean ± SEM of three independent experiments. #p<0.05; *p<
0.01, compared to vehicle. (D) Histograms show the percent of viable cells after
treatment of PC12-Tuni (top) and PC12-A53TSyn (bottom) with the indicated doses of
caffeine. PC12 cells were treated with caffeine either in vehicle for 2 or 24 h or in
combination with Tuni for 26 h. In PC12 cells expressing VT, WT and A53T, caffeine
was added 24 h after induction and then left incubated for another 24 h. Cell viability
was determined by trypan blue exclusion. Values represent the mean ± SEM of three
separate experiments. *p<0.01, #p<0.05, compared to vehicle control or VT at each time
point and between the indicated groups.

(E) qRT-PCR analysis of the relative
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expression of ER-stress proteins and Ca2+ release channels in PC12 cells treated with
Tuni (+) for the indicated time points. Values represent the mean ± SEM of nine
separate experiments. #p<0.05; *p< 0.01, compared to vehicle. (F) qRT-PCR analysis of
the relative expression of IP3R1 and RYR1 in the indicated PC12 cells ectopically
expressing empty vector (VT), wild-type (WT) or mutant (A53T) Syn. Cells were
harvested 48 h after expression. Values represent the mean ± SEM of three separate
experiments. #p<0.05; *p< 0.01, compared to VT.

Supplementary Figure 2-2. Knockdown of ER Ca2+ release channel expression
ameliorates ER stress
(A, B) Representative immunoblots (top) and results of densitometric analysis (bottom)
of Herp, Grp94/78, CHOP, and PS1 protein levels in PC12 cells that were transfected
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with siRNA-IP3R1 (250 nM) (A) or a combination of siRNA-RYR1 and siRNA-RYR3
(100 nM each) (B) for either 8 and 24 h prior to the addition of tunicamycin (Tuni; 20
g/ml) or vehicle alone (Con). Values represent the mean ± SEM of three independent
experiments. *p< 0.01, compared to Con and between the indicated groups.

Supplementary Figure 2-3. Inhibition of ER Ca2+ release reduces Syn inclusions
formation
(A) Representative images of Syn inclusions (indicated by arrowhead) in PC12 cells
transfected with either the GFP-tagged WTSyn or GFP-tagged mutant (A53T) Syn
construct. Twenty four hours after transfection, PC12 cells were treated with
Xestospongin (5 µM), Salubrinal (Sal; 75 µM) or the respective vehicles for another 24
h, fixed, and counterstained with the nuclear dye 4',6-diamidino-2-phenylindole (DAPI;
blue). (B) Histograms show the percentage of the indicated transfected PC12 cells with
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cytoplasmic Syn protein inclusions. Values represent the mean ± SEM of three
cultures in triplicate. #p< 0.05; *p< 0.01, compared to vehicle controls.

Supplementary Figure 2-4. Levels of phospho-eIF2 and total eIF2 following
tunicamycin and/or salubrinal treatments
A representative blot of phospho-eIF2 and total eIF2 in PC12 cells that were treated
with either salubrinal (Sal; 75 µM) or tunicamycin (Tuni; 20 g/ml) alone, or in
combination. Cells were harvested 12 h after treatments.
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Supplementary Figure 2-5. Salubrinal reduces bradykinin-evoked Ca2+ transients
in PC12-Tuni and PC12-α A53TSyn cells
(A) Representative images of the bradykinin-induced changes in the fluo-4
fluorescence intensity in PC12 cells that were treated with tunicamycin (Tuni; 20 g/ml)
for 18 h in the presence of salubrinal (Sal; 75 µM) or vehicle control (Con).

(B)

Representative recordings of the bradykinin (BK; 10 μM)-induced elevation of
intracellular Ca2+ ([Ca2+]i) in PC12 cells after expression of mutant (A53T) -Syn in the
presence of Sal or Con. PC12 cells transfected with the empty vector (VT) were
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included as controls. Cells were loaded with fura-2 and [Ca2+]i was recorded in Ca2+ free
medium

as described under “Materials and Methods”. Arrow indicates time of BK

addition. Histograms show Ca2+ peak values (change from baseline) and AUC (area
under the curve). Values are the mean ± SEM of determinations made in 4 to 6
separate cultures (15-20 cells assessed/culture). #p<0.05,*p<0.01, ^p<0.001, compared
to VT.

Supplementary Figure 2-6. Densitometric and qRT-PCR analyses of ER stress
proteins and ER-resident Ca2+ release channel levels
(A, B) Results of densitometric analysis of ER stress proteins and ER Ca 2+ release
channels in the indicated PC12 cells 24 h after transfection with siRNA-Con or siRNA83

Herp (100 nM). Values represent the mean ± SEM of three independent experiments.
#

p< 0.05; *p< 0.01, compared between the indicated groups. (B) Results of

densitometric analysis of ER stress proteins and ER Ca 2+ release channels in the
indicated PC12 cells 48 h after ectopic expression of Herp. Values represent the mean
± SEM of three independent experiments. #p< 0.05; *p< 0.01, compared between the
indicated groups. (C, D) qRT-PCR analysis of the relative expression of ER-resident
Ca2+ release channels in the indicated PC12 cells 24 h after addition of siRNAs or
ectopic expression of Herp. Values are the mean ± SEM of three independent
experiments. #p< 0.05; *p< 0.01, compared between the indicated groups.

Supplementary Figure 2-7. Herp interacts with ER-resident Ca2+ release channels
and A53TαSyn
(A) A representative immunoblot shows absence of Grp78 in the protein complex
immunoprecipitated (IP) by anti-Herp antibody from total lysates of PC12 cells treated
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with tunicamycin (Tuni; 20 g/ml) or vehicle for 16 h. Input shows Grp78 in total lysates.
The pre-immune normal IgG used as control for IP. (B) A representative immunoblot
shows the presence of IP3R (top) and pan-RYR (bottom) in protein complexes IP by
anti-c-Myc antibody from total lysates of HEK293 cells that were transiently transfected
with the c-myc-tagged Herp for 24 h. The pre-immune normal IgG was used as the
negative control for IP. Note that IP3R1 but not pan-RYR was readily detected in the
inputs. (C) Representative immunofluorescence micrographs show co-localization of
Herp (green) with IP3R (red) and pan-RYR (red) in PC12 cells that were treated with
either vehicle (top) or Tuni (bottom) for 24 h. (D) Representative immunoblots show the
presence of Herp or Syn in protein complexes IP by anti- Syn or anti-c-myc antibody,
respectively, from total lysates of PC12 cells that were transiently transfected with both
A53TSyn and c-myc-tagged Herp for 24 h. The pre-immune normal IgG was used as
the negative control for IP. Inputs verify the presence of c-myc-tagged Herp or Syn in
lysates. (E) Representative immunoblots show the presence of Herp or Syn in protein
complexes IP by anti- Syn (top) or anti-Herp (bottom) antibody, respectively, from total
lysates of PC12 cells that were transiently transfected with either Herp (top) or
A53TSyn (bottom) for 24 h. The pre-immune normal IgG was used as the negative
control for IP. Inputs verify the presence of c-myc-tagged Herp or Syn in lysates.

85

Supplementary Figure 2-8. Blockade of proteasome inhibits Herp- induced
degradation of ER-resident Ca2+ release channels
(A) Results of densitometric analysis of Herp, IP3R1 and pan-RYR protein levels in
PC12 cells that were treated with the indicated doses of the proteasomal inhibitor MG132 or vehicle as control (Con) for 3, 6, 12, and 24 h. Values are the mean ± SEM of
three independent experiments. #p<0.05; *p<0.01, compared to Con. (B) Results of
densitometric analysis of Herp, IP3R1, and pan-RYR protein levels in PC12 cells
transfected with either a plasmid expressing Herp or an empty plasmid (Vector) 24 h
prior to the addition of 1 M MG-132. Cells were collected at the indicated time points
after MG-132 addition. Values are the mean ± SEM of three independent experiments.
#

p<0.05; *p<0.01, compared between the indicated groups.
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Supplementary Figure 2-9. Herp interacts and co-localizes with the ubiquitininteracting S5a subunit of the proteasome
(A) A representative immunoblot of Herp immunoprecipitated (IP) by anti-S5a antibody
from total lyates of PC12 cells that were treated with Tuni (20 g/ml) for 16 h. Preimmune normal IgG was used as a negative control for IP. Inputs verify the amounts of
Herp in lysates. Light chain indicates equal amounts of normal IgG and anti-S5a IgG in
the protein complexes. (B) Representative immunofluorescence micrographs showing
the co-localization of S5a (red) with either Herp or Grp78 (green) in PC12 cells exposed
to Tuni or vehicle for 12 h. (C) A representative immunoblot of S5a protein in PC12 cells
exposed to Tuni or vehicle for 16 h. (D) Representative immunofluorescence
micrographs showing the co-localization of S5a (red) with Herp (green) in PC12 cells
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transfected with siRNA-Con or siRNA-Herp 24 h prior to exposure to Tuni for another 14
h.

Supplementary Figure 2-10. Accumulation of ER stress markers and of ERresident Ca2+ channels in A53TαSyn transgenic mice
(A) Representative immunofluorescence micrographs showing the immunoreactivities
of antibodies directed to the indicated proteins in the lumbar spinal cords from presymptomatic (5 months) and symptomatic (13-15 months) A53T mice. (B) mRNA levels
of the indicated proteins in the lumbar spinal cords from 13-15 months old nontransgenic (Non-Tg) and mutant Syn (A53T) mice. Values are the mean ± SEM of four
mice per group. *p<0.01, compared to Non-Tg. (C) A representative immunoblot of
Syn in protein complexes immunoprecipitated (IP) with anti-Herp antibody from lumbar
spinal cord homogenates of 13-15 months old Non-Tg and A53T mice. Pre-immune
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normal IgG was used as a negative control for IP. Inputs verify the amounts of Syn in
spinal cord extract as determined by immunoblotting using an antibody to mouse and
human Syn.

Summary Diagram 2-1. Schematic representation summarizing the mechanisms
involved in Syn-induced activation of ER stress-associated apoptosis
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Tables
Table 2-1. Target sequences of siRNA duplexes

Table 2-2. Primer sets used for the detection of transcripts by semi-quantitative
PCR
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Table 2-3. Primer sets used for the detection of transcripts by quantitative realtime PCR (qRT-PCR).
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CHAPTER THREE: THE HOMOCYSTEINE-INDUCIBLE ENDOPLASMIC
RETICULUM STRESS PROTEIN COUNTERACTS CALCIUM STORE DEPLETION
AND INDUCTION OF CCAAT ENHANCER-BINDING PROTEIN HOMOLOGOUS
PROTEIN IN A NEUROTOXIN MODEL OF PARKINSON DISEASE
This research was originally published in Journal of Biological Chemistry. Srinivasulu
Chigurupati, Zelan Wei, Cherine Belal, Myriam Vandermey, George A Kyriazis, Thiruma
V Arumugam, and Sic L Chan. The homocysteine-inducible endoplasmic reticulum
stress protein counteracts calcium store depletion and induction of CCAAT enhancerbinding protein homologous protein in a neurotoxin model of Parkinson Disease.
Journal of Biological Chemistry. 2009; 284(27):18323–18333. © the American Society
for Biochemistry and Molecular Biology.
Introduction
Parkinson

disease

neurodegenerative

(PD)

disorder

that

is

the
results

second
in

the

most

common

selective

age-related

degeneration

of

dopaminergic neurons of the substantia nigra pars compacta (1, 2). The proximate
cause of selective degeneration of dopaminergic neurons in PD has not been
clearly elucidated.

Several mechanisms are inferred

to play a role in the

pathogenesis of PD based on studies from animals or in vitro studies using
dopaminergic neurotoxins. These include mitochondrial dysfunction, oxidative
stress, and impairment of the ubiquitin-proteasomal pathway (UPP) (1–3). It has
been shown that several genes that are mutated in familial PD encode for proteins
that have functions linked to UPP and mitochondria (1–3). The UPP plays a critical
role in ER-associated protein degradation (ERAD), a protein quality control system
of the ER that eliminates misfolded proteins i n the ER lumen (4). UPP dysfunction
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results in the accumulation of misfolded or unfolded proteins within the ER, which
induces ER stress (5).
Important roles for ER stress and ER stress-induced cell death have been
reported in a broad spectrum of pathological conditions (6). To alleviate ER stress
and enhances cell survival, cells launch the unfolded protein response (UPR), an
adaptive response to minimize accumulation of misfolded proteins that would
otherwise be toxic to the cell (7). The biological objectives of the UPR are to reduce
the overall protein translation, increase the production of ER localized chaperones,
and increase the clearance of unfolded proteins by UPP (7). Although short time UPR
activation serves to reduce the unfolded protein load, a protracted activation of UPR,
as the result of either severe or prolonged ER dysfunction, activates the cell death
program (7). Important mediators of ER stress-associated death include the
activation of the ER-associated procaspase-12 (in mouse) or procaspase-4 (in
human) and increased expression of the pro-apoptotic transcription factor CCAAT
enhancer-binding protein homologous protein (CHOP, also termed as growth
arrest-DNA damage response protein or Gadd153) (8).
Recent studies have demonstrated hallmarks of ER stress in several
experimental models of PD (9 –12) and in dopaminergic neurons in the substantia
nigra of PD subjects (13). Although these studies indicate that ER stress is closely
associated with PD, it is yet not clear whether and how ER stress contributes to the
degenerative cascades in PD. Cells that fail to respond to ER stress are more
sensitive to neurotoxin-induced death (9), suggesting that up-regulation of ER stress
proteins, at least during the early phase of the ER stress response, is important to
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restore ER homeostasis and to prevent activation of the ER stress-induced
apoptotic program. Consistent with this notion, preconditioning with a sublethal
level of ER stress has been shown to protect cells, in part through up-regulation
of ER stress proteins. Hence, understanding the molecular mechanisms by which
ER stress proteins overcome ER stress may help to uncover novel approaches to
block the ER stress-associated pathological processes in cell culture and animal
models of PD (9–12).
Herp (homocysteine-inducible ER stress protein) is a membrane-bound,
ubiquitin-like protein that is located in the ER (14). Herp expression is strongly upregulated in cultured primary neurons exposed to proteasomal inhibitors or
pharmacological agents

that selectively induce ER dysfunction (14–16). We

previously reported that overexpression of Herp promotes neuronal survival,
whereas knockdown of Herp protein by small interference RNA enhances vulnerability
to ER stress- and amyloid β-peptide-induced apoptosis (16). The ability of Herp to
prevent ER stress-induced death was correlated with its ability to stabilize cellular
Ca2+ homeostasis (16, 17). Here, we investigated the role of Herp in the cellular
response to 1-methyl-4-phenylpyridinium (MPP+), a neurotoxicant commonly used
to elicit experimental models of PD (18). Because disturbances in intracellular Ca2+
homeostasis have been implicated in oxidative cell injury (19), we test the
hypothesis of whether Herp may play a role in counteracting MPP+-induced
disturbances in intracellular Ca2+ homeostasis. Our results indicate that knockdown
of Herp increases MPP+-induced CHOP expression, ER Ca2+ leakage, and
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vulnerability to MPP+-induced cytotoxic cell death, suggesting that Herp is critical for
survival adaptation to this PD neurotoxin.

Materials and Methods
Materials
1-methyl-4-phenylpyridinium (MPP+) and tunicamycin were purchased from
Sigma Chemical. Lactacystin and LLVY-AMC were obtained from BioMol. The
antibodies for Herp and CHOP were obtained from BioMol and Santa Cruz
Biotechnology. The antibody for ERK1 was obtained from Cell Signaling. The antibodies
to Grp78 and Bcl-2 were purchased from Stressgen and Millipore, respectively.
Secondary antibodies conjugated to horseradish peroxidase (HRP) were from Jackson
Immunoresearch, respectively. 7-dichloro-dihydrofluorescein diacetate (DCF-DA) was
obtained from Molecular Probes.

Generation of DNA Constructs
Plasmids containing the full-length or mutant deletion human Herp cDNA
were constructed as described previously (16). Site-directed mutagenesis was
performed to generate by a PCR-based primer overlap extension method. In brief,
the same pair of flanking primers and two different mutant overlapping primers were
synthesized as described (16). The PCR products that contained the mutant
sequence were subcloned into the PCR4 TOPO TA cloning vector (Stratagene),
which was then amplified and digested with BamHI and EcoRII and subcloned into
the pcDNA3.1 vector. The mutation was confirmed by automated DNA sequencing.
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Generation of Stably Transfected Cell Lines
Transfection of PC12 cells was carried out using the Lipofectamine reagent
(Invitrogen) as previously described (16). Stably expressing clones were obtained
after selection for growth in the presence of geneticin (500 mg/liter) and
characterized for Herp expression by immunoblot analysis. For experiments,
PC12 cells were plated onto glass coverslips and used between 18 and 48h after
plating. Cells stably transfected with the empty vector were used as controls.

Experimental Treatments
PC12 and MN9D cells were treated with MPP+ (1 mM), tunicamycin (5 µg/ml),
and lactacystin (5 µM) in OPTI-MEM (Invitrogen). Each of these compounds was
prepared in Me2SO immediately before applying them to the cultures. When Me2SO
was used as the solvent, their final concentration did not exceed 0.1%. At the end of
each treatment, the cultures were processed for immunoblotting and for evaluating
the extent of cell death.

RNA Interference
Herp and CHOP siRNA duplexes are designed to specifically target the 21nucleotide

region

5'-CGC-AACAAATAGTCGGAACATC-3'

(NM_004562.1) and

of

the

Herp

gene

5'-CTCTTGACCCTGCATCCCTA-3' of the CHOP

gene

(nucleotides 270 –291; NM_024134). These target sequences were chosen based
on previous experiments testing the gene-silencing effectiveness of three to four
siRNA duplexes (16, 20). Blast searches confirmed that these sequences were not
homologous to any genes. A previously described scrambled sequence (20) is used
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as siRNA-Control. The cells were transfected with the siRNA duplexes using
Lipofectamine 2000 (Invitrogen) in Opti-MEM according to manufacturer’s protocol.
After overnight incubation, the cultures were washed and replaced with 2 ml of fresh
serum containing Dulbecco’s modified Eagle’s medium to allow recovery for 24 h. To
monitor knockdown, the cells were harvested and processed for RT-PCR and/or
Western blot analyses.

Quantification of Cell Survival
Cell viability was assessed by the trypan blue exclusion method and the
lactate dehydrogenase release assay as described previously (16, 20). Cell viability
was evaluated in triplicates for each treatment. All of the experiments were
repeated at least three times.

RNA Isolation and RT-PCR
Total RNA from cells grown on 100-mm dishes was isolated with TRIzol
(Invitrogen), and 2 µg of RNA was reverse transcribed with Superscript II reverse
transcriptase and an oligo(dT) primer (Invitrogen). Semi-quantitative RT-PCR
analyses of Herp, CHOP, and glyceraldehyde-3-phosphate dehydrogenase were
performed using the following pairs of primers:
rat

Herp,

5'-CCACTACCACAACTACCA-CTG-3'

CCTCTCTTTGGCTTTCTGGAA-3'
dehydrogenase,

(reverse);

rat

(reverse);

AAGGTCTACGAAGGTGAACGACCCC-3

(forward)
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and

5'-

glyceraldehyde-3-phosphate

5'-TGTGATGGACTCCGGTGACGG-3'

ACAGCTTCTCTTTGATGTCACGC-3'

(forward)

(forward)
rat

and

5'-

CHOP,

5'-

and

5'-

GACCCCAAGACACGTGAGCAACTGC-3'

(reverse);

CCACAAGGATGCAGACATTG-3'

rat

(forward)

Grp78/Bip,5'and

5'-

AGGGCCTCCACTTCCATAGA-3' (reverse); and rat glyceraldehyde-3-phosphate
dehydrogenase

(which

served

as

an

internal

control),

5'-

CCACAAGGATGCAGACATTG-3' (forward) and 5'-AGGGCCTCCACTTCCATAGA3' (reverse).

Measurement of ER and Mitochondrial Ca2+ Concentrations
2+
E]ER) will be evaluated using the ER-targeted YC4
Free Ca2+ levels in the ER ([Ca
R

(YC4-ER; gift of Dr. W. F. Graier, University of Graz), a low affinity ratiometric
“cameleon” indicator with a KDEL sequence and a calreticulin signal peptide, as
previously described (21). For measurement of mitochondria Ca2+ level ([Ca2+]M),
the mitochondria-targeted ratiometric-pericam (RP-mt; gift of Dr. A. Miyawaki,
RIKEN Brain Science Institute) was used as described previously (22). Briefly, cells
plated at 60% confluency on glass coverslips were transiently transfected with 2 g of
p-BudCR4.1-YC4-ER or pcDNA3-Rp-mt using Lipofectamine. Twenty-four hours
after transfection, the cells were incubated with MPP+, and changes in [Ca2+]ER

and

[Ca2+]M were monitored by confocal laser scanning imaging system with excitation
set at 440 nm (for YC4-ER) or at 433 and 485 nm (for Rp-mt). Emission was
monitored at 485 and 535 nm (for YC4-ER) or at 539 nm (for Rp-mt). Measurements
were performed in Locke’s buffer containing: 154 mM NaCl, 5.6 mM KCl, 2.3 mM CaCl2,
1.0 mM MgCl2, 3.6 mM NaHCO3, 5 mM HEPES, and 10 mM D-glucose, pH 7.2 (16, 20).
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The data were expressed as the ratios of the fluorescence in treated relative to
untreated cultures.

Protein extraction, immunoprecipitation, and Western blotting
Cell lysates for Western blotting were prepared in T-PER lysis buffer (Pierce). In
all experiments, the same amount of total protein was loaded for each sample. The
membranes were probed with the primary antibodies: Herp, Grp78/Bip, CHOP and
ERK1, followed by horseradish peroxidase conjugated secondary antibody and
developed with the Super Signal West Pico Chemiluminescent substrate (Pierce). For
immunoprepitation, aliquots of cell lysates containing 300 µg of protein were incubated
with rabbit polyclonal Herp antibody in immunoprecipitation buffer (150 mM NaCl, 2 mM
EDTA, 1% Nonidet P-40, 5 µg/ml leupeptin, 5 µg/ml aprotinin, 2 µg/ml pepstatin A,
0.25 mM phenylmethylsulfonyl fluoride, 50 mM Tris, pH 7.6). Antigen-antibody
complexes were precipitated with immobilized protein A, washed three times in
immunoprecipitation buffer, and solubilized by heating in Laemmli buffer containing 2mercaptoethanol at 100 °C for 4 min. The solubilized proteins were separated by SDSpolyacrylamide gel and then immunoblotted with a polyclonal antibody to Bcl-2.

Proteasomal activity
Chymotrypsin-like activity of proteasome was assayed using the fluorogenic
peptide Suc-Leu-Leu-Val-Tyr-7-amino-4-methylcoumarin (LLVY-AMC) according to the
method reported previously (15). Briefly, after the treatment with MG132 or lactacystin
for 30 min, cultures were harvested, lysed in proteasome buffer (10 mmol/L Tris–HCl,
pH 7.5, 1 mmol/L ethylene diamine tetraacetic acid (EDTA), 2 mmol/L adenosine-5'103

triphosphate, 20% glycerol, and 4 mmol/L dithiothreitol), and centrifuged at 13, 000 g at
4 °C for 10 min. The supernatant (20 µg of protein) was then incubated with proteasome
activity assay buffer (0.05 mol/L Tris–HCl, pH 8.0, 0.5 mmol/L EDTA, 40 µmol/L LLVYAMC) for 1 h at 37 °C. The reaction was stopped by adding 0.9 mL of cold water and
placing the reaction mixture on ice for at least 10 min. Subsequently, the fluorescence of
the solution was measured by Fluorescence Microplate Reader with excitation at 380
nm (Ex) and emission at 440 nm (Em). All readings were standardized relative to the
fluorescence intensity of an equal volume of free 7-amino-4-methylcoumarin solution.

Statistical analysis
Comparison between two groups was performed using Student's t-test, whereas
multiple comparisons between more than two groups were analyzed by one-way
ANOVA and post hoc tests. The data evaluated for the effects of two variables were
analyzed using two-way ANOVA. The results are presented by mean ± standard
deviation. For all analyses, statistical significance is defined as p-value of ≤0.05.

Results
Herp Is Required for Survival Adaptation to MPP+-induced ER Stress
Several ER stress

inducible

proteins such

as Grp78 and

Herp are

constitutively expressed. To address the role of Herp in the MPP+-induced cell
death

model, we used RNA interference to knockdown endogenous Herp

expression. Transfection of PC12 cells with a siRNA that targets Herp (siRNA-Herp)
resulted in a substantial reduction in the level Herp protein (Fig. 1A). To evaluate
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the effect of Herp knockdown on neuronal vulnerability to MPP+ toxicity, we
assessed cell viability by using the trypan blue exclusion (Fig. 1B) and lactate
dehydrogenase release (not shown). Exposure of cultures to 0.5 mM MPP+ induced~
45–50% cell death within 24 h. Depletion of Herp protein markedly enhanced the
vulnerability of PC12 cells to MPP+ toxicity. Compared with cultures transfected with
a scramble control siRNA (siRNA-Con), there were significantly more dead cells in
cultures treated with siRNA-Herp, indicating that down-regulation of Herp sensitizes
PC12 cells to MPP+-induced death (Fig. 1B). Similar results were obtained in MN9D,
a midbrain-derived dopaminergic neuronal cell line (Fig. 1B). Next, we determined
whether PC12 cells stably overexpressing Herp (PC12-Herp) are resistant to MPP+induced death. Herp protein overexpression was confirmed in three independent
clones by immunoblotting (Fig. 1C). Compared with PC12-VT, PC12-Herp cells
were significantly more resistant to 0.5 mM MPP+ (Fig. 1D), a dose that yielded ~50%
cell death 24 h post-treatment (Fig. 1B). Collectively, the results indicate that survival
adaptation to MPP+ is dependent on Herp function.
Given that Herp expression is responsive to ER stress (14 –16) and that ER
stress has been shown to accompany neurotoxin-induced death (9 –11), we next
evaluated whether MPP+ may induce the expression of Herp. Levels of Herp mRNA
and protein in PC12 cells were not markedly increased after exposure to MPP+ (Fig.
2A). The same dose of MPP+ also failed to robustly increase Herp protein expression
in MN9D cells (Fig.2B), thus excluding the possibility that the observed anomaly in
Herp induction was cell type-specific. By contrast, the protein level of Grp78, a
marker of ER stress, was transiently up-regulated in PC12 and MN9D cells by MPP+
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(Fig. 2, A and B), indicating activation of the ER stress response by MPP+. For
comparison, we treated sister cultures with tunicamycin, a known pharmacological
ER stressor that causes protein accumulation in the ER by inhibiting protein
glycosylation (16). Levels of both Herp and Grp78 protein were robustly up-regulated
in both PC12 and MN9D cells after treatment with tunicamycin (Fig. 2C). Taken
together, the above results suggest that cells are unable to induce Herp protein
expression in response to MPP+.

Herp Counteracts MPP+-induced Perturbation of ER Ca2+ Homeostasis
Oxidative stress is an important factor implicated in the disruption of
neuronal Ca2+ homeostasis (23). Consistent with previous reports (24, 25), MPP+
increased the intracellular accumulation of hydroxyl and peroxynitrite in PC12 and
MN9D cells (Supplemental Fig. S1). Given that perturbations of intracellular Ca2+
homeostasis have been implicated in oxidative stress-induced cell death (19), we
next examined the effects of MPP+ on ER Ca2+ handling. To this end, we monitor
changes in the Ca2+ concentration in the ER lumen ([Ca2+]ER) of PC12 and MND9D
cells at various time points after treatment with MPP+. The early rise in [Ca2+]ER was
quickly followed by a gradual and progressive decline in MPP+-treated cells (Fig. 3A),
suggesting that MPP+ increased Ca2+ leakage from the ER.
Because Herp functions to stabilize ER Ca2+ homeostasis during ER stress
(16, 17), we next evaluated whether overexpression of Herp prevents MPP+-induced
perturbations of [Ca2+]ER. Compared with PC12-VT cells, PC12-Herp cells exhibited
reduced ER Ca2+ leakage and were able to maintain [Ca2+]ER (Fig. 3B). Because
uncontrolled ER Ca2+ release can lead to protracted rise in the Ca2+ concentration
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2+
and because aberrant mitochondrial Ca2+
E
M
of the mitochondria
([Ca
]M) (8, 29) M
R

handling has been shown to be involved in MPP+-induced toxicity (30, 31), we next
assessed changes in [Ca2+]M in PC12 and MN9D cells at various time points after
treatment with MPP+. The decrease of [Ca2+]ER was accompanied by an increase in
[Ca2+]M in MPP+-treated cells (Fig. 3C), indicating that MPP+ induces Ca2+
mobilization from the ER to mitochondria. As expected, the magnitude of the
increase in [Ca2+]M was significantly attenuated in PC12-Herp (Fig. 3D), suggesting
that Herp likely inhibits the toxic Ca2+ transfer from the ER to mitochondria under
oxidant-induced ER stress. Representative pseudocolored images of the indicated
PC12 clones expressing the fluorescent Ca2+ indicators, YC4-ER and pericam-mt,
are shown in Fig. 3 (B and D), respectively. Co-localization studies confirmed that the
indicated fluorescent indicators are properly targeted and expressed either in the ER
(YC4-ER) or in the mitochondria (pericam-mt) (Supplemental Fig. S3).

Herp Blocks MPP+-induced Activation of CHOP
CHOP has been implicated as a mediator of apoptosis in the context of ER
and oxidative stress (32, 33). ER stress-induced cell death in cultures occurs only
when CHOP is permanently up-regulated but not when the increase in CHOP is
transient, suggesting that CHOP contributes to the activation of ER-initiated
apoptosis signaling (31–34). Given that store depletion has been associated with
CHOP up-regulation (20, 35) and that overexpression of Herp counteracts MPP+induced ER Ca2+ store depletion (Fig. 3B), we next evaluate whether CHOP is
differentially induced by MPP+ in PC12-VT and PC12-Herp clones. The magnitude of
the MPP+ induced increase in CHOP protein level was significantly lower in PC12107

Herp when compared with PC12-VT (Fig. 4A). The Herp-mediated suppression of
CHOP was also associated with reduced Grp78 induction (Fig. 4A), suggesting that
Herp restores ER homeostasis in MPP+-treated cells by inhibiting downstream
events caused by CHOP.
By contrast, suppression of endogenous Herp

by RNA interference

potentiates CHOP induction in MPP+-treated PC12 cells (Fig. 4B). Treatment with
siRNA-Con, which had no effect on Herp expression (Fig. 1A), did not enhance
MPP +-induced CHOP up-regulation (Fig. 4B). These data are consistent with a
previous study showing that Herp null cells displayed aberrant ER stress signaling
with increased level of CHOP transcript when compared with wild-type control cells
(15).
Next, we determined whether suppression of CHOP induction by RNA
interference is sufficient to inhibit MPP+ toxicity. siRNA targeting CHOP (siRNACHOP) (20) was used to inhibit the MPP+-induced CHOP expression in PC12 cells
(Fig. 4C). Cell viability assessed by trypan blue exclusion assay showed that siRNAinduced silencing of CHOP provided significant protection against MPP+ toxicity (Fig.
4D). By contrast, the siRNA-Con did not rescu PC12 cells from MPP+ toxicity (Fig.
4D). Interestingly, knockdown of CHOP did not further rescue PC12-Herp cells from
MPP+-induced toxicity (Supplemental Fig. S2), suggesting that Herp promotes cell
survival in large by suppressing CHOP-dependent pro-apoptotic signaling.
Collectively, the above results indicate that Herp attenuates MPP+-induced cell
death by inhibiting CHOP up-regulation.
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CHOP Contributes to MPP+-induced Perturbation of ER Ca2+ Homeostasis
To determine whether CHOP up-regulation in MPP+-treated cells is causally
linked to ER Ca2+ store depletion, we measured the MPP+-induced perturbation in
ER Ca2+ homeostasis in PC12 cells transfected with siRNA-CHOP. Compared with
siRNA-Control, siRNA-CHOP substantially r e d u c e d ER Ca2+ leakage in MPP+treated PC12 cells. CHOP knockdown also attenuates MPP+-induced ER Ca2+
store depletion (Fig. 5A). Because Herp suppressed CHOP induction in MPP+treated PC12

cells, we

examined whether knockdown of Herp expression

exacerbated MPP+-induced ER Ca2+ store depletion. As expected, knockdown of
Herp exacerbated ER Ca2+ leakage (Fig. 5B) in MPP+-treated PC12 cells (Fig. 5C).
These data indicate that Herp prevents CHOP-mediated ER Ca2+ store depletion in
MPP+-treated PC12 cells.

The Herp-dependent Protective Mechanism Is Not Mediated by the Antiapoptotic Bcl-2 Protein
Because CHOP has been shown to down-regulate the expression of Bcl-2
protein (36) and because overexpression of Bcl-2 affects Ca2+ handling by the ER (8,
37), we next determined whether Bcl-2 protein may be acting downstream of Herp to
maintain ER Ca2+ homeostasis in MPP+-treated PC12 cells. Levels of Bcl-2 protein
in PC12-VT and PC12-Herp were not significantly different before and after exposure
to MPP+ (Supplemental Fig. S4). To rule out the possibility that Herp might interact
with Bcl-2 and therefore facilitated Bcl-2 association with the ER membrane, we
measured the amounts of Bcl-2 protein in isolated microsomes. Levels of Bcl-2
protein in the microsomes prepared from PC12-Herp were comparable with those
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from

PC12-VT and

were

nearly

unchanged following exposure

to

MPP+

(Supplemental Fig. S4). No interaction between Bcl-2 and Herp was detected by coimmunoprecipitation analysis (Supplemental Fig. S4). All in all, although Herp
affects Ca2+ handling by the ER in a manner resembling the effects of Bcl-2
overexpression, data from these experiments excluded a role for Bcl-2 in the Herpdependent stabilization of ER Ca2+ homeostasis in MPP+-treated cells.

The Ubiquitin-like (UBL) Domain Is Essential for Herp-mediated ER Ca2+
Stabilization and Protection from MPP+-induced Toxicity
Previous studies established a critical role of the N-terminal UBL domain in
the cytoprotective action of Herp (15–17). Overexpression of a mutant Herp deletion
construct lacking the UBL domain (UBL-Herp; Fig. 6A) failed to protect PC12 cells
from ER stress-induced cell death (15–17). To determine whether the Herpdependent protection against MPP+ toxicity may also require the UBL domain, we
generated PC12 clones stably overexpressing UBL-Herp. Stable transfection
inducing overexpression of UBL-Herp was verified by immunoblotting (Fig. 6A).
Compared with PC12-VT, PC12-UBL -Herp clones were not more resistant to
MPP+-induced cell death (Fig. 6B), suggesting that the UBL domain is required for
Herp-dependent cytoprotective action.
To determine whether the UBL domain is essential for the stabilization of ER
Ca2+ homeostasis, we measured [Ca2+]ER in PC12-UBL -Herp. The magnitude of
the MPP+-induced ER Ca2+ leakage was indistinguishable in PC12-VT and PC12UBL -Herp, suggesting that the UBL domain is required f o r the ability of Herp to
maintain ER Ca2+ homeostasis (Fig. 6C). We also found that CHOP mRNA and
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protein levels in PC12-VT clones are not significantly different in PC12-UBL - Herp
clones (Fig. 6D), which further supports the notion that a functional Herp protein is
required to suppress CHOP induction and to stabilize ER Ca2+ homeostasis.

Herp-dependent Stabilization of ER Ca2+ Homeostasis Requires a Functional
UPP
Herp has recently been implicated in the regulation o f ERAD (38, 39), a
protein quality control system of the ER, which eliminates misfolded proteins by UPPdependent degradation (4). To determine whether ERAD is involved in the Herpdependent stabilization of ER Ca2+ homeostasis, we blocked ERAD with the
proteasomal inhibitor lactacystin. Treatment of PC12 cells with lactacystin for 12
and 24 h significantly reduced proteasomal activity (Supplemental Fig. S5).
Inhibition of proteasome function reversed the Herp-dependent suppression of
CHOP induction (Fig. 7A) and accelerates ER Ca2+ depletion (Fig. 7B), suggesting
that proteosomal activity is required for Herp-dependent stabilization of ER Ca2+
homeostasis. Consistent with the notion that the proteasomal function i s required
for the neuroprotective action of Herp, we found that lactacystin not only increased
the vulnerability of PC12 cells (Fig. 7C) but also restores the sensitivity of PC12-Herp
clones to MPP+ toxicity (Fig. 7D).

Discussion
Elucidating the specific and sequential molecular events induced by MPP+ will
provide a better understanding of the molecular basis of dopaminergic cell death.
MPP+ is selectively toxic to dopaminergic neurons and has been studied extensively
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as an etiologic model of PD because mitochondrial dysfunction is implicated in both
MPP+ toxicity and the pathogenesis of PD. MPP+ toxicity has been attributed to the
generation of reactive oxygen species (ROS) (24, 25). ROS generated from
mitochondrial appear t o be a main contributor of oxidative stress-mediated
neurodegeneration in PD models (40).
Oxidative stress is an important factor implicated in the disruption of
neuronal Ca2+ homeostasis (19). In this study we showed that MPP+ induces the
deregulation of ER Ca2+ homeostasis. There is a growing body of evidence that the ER
can play pivotal roles in regulating cell survival and apoptosis in a variety of cell types
including neurons. The ER serves many specialized functions in the cells including
the biosynthesis of membrane and secretory proteins (7) and maintenance of
neuronal Ca2+ homeostasis (41). Dysregulation of ER Ca2+ homeostasis occurs as
an early event during many forms of apoptosis and has been implicated in the
pathophysiology of several acute and chronic neurodegenerative diseases, including
ischemic injury, trauma, and Alzheimer, Huntington, and prion diseases (41– 43).
Uncontrolled Ca2+ release from the ER is a key proapoptotic event, as indicated by
the ability of blockers of ER Ca2+ release to reduce the extent of ischemic injury (44)
and to protect cultured neurons against cell death induced by glutamate, mutant
huntingtin, Aβ, and prion peptides (21, 45). Whether dysregulation of ER Ca2+
homeostasis contributes to PD initiation and progression has not yet been
established.
Disturbances in intracellular Ca2+ homeostasis could

play a role in

dopaminergic degeneration because treatment with various PD neurotoxins has
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been shown to perturb intracellular Ca2+ homeostasis (26 –28). The MPP+-induced
cell death was inhibited by co-expression of calbindin-D28K or co-treatment with
BAPTA (1,2-bis-(o-aminophenoxy)-ethane-N,N,N',N'-tetracidic acid), suggesting a
critical role for intracellular Ca2+ loads in MPP+-induced toxicity (46). The pertinent
mechanism whereby neurotoxins disrupt intracellular Ca2+ homeostasis remains
poorly understood. Antagonists of glutamate and Ca2+ channels (47) have been
reported ineffective

in preventing

MPP+ toxicity, suggesting that

the Ca2+

perturbations induced by MPP+ are likely attributed to deregulated ER Ca2+ release.
Consistent with the latter notion, inhibition of ER Ca2+ release prevents the MPP+induced perturbations of intracellular Ca2+ (47).
Various pathological conditions that induce ER stress have been Mshown to
perturb ER Ca2+ homeostasis (8, 16, 29), but the underlying mechanisms remain
poorly characterized. Oxidative damage to the ER can lead to perturbations in ER
Ca2+ homeostasis. Protein folding in the ER can generate ROS, which in turn may
exacerbate ER stress by perturbing the function of ER foldases and/or chaperones
(48). ROS could also sensitize ryanodine receptor- and inositol triphosphate
receptor-mediated ER Ca2+ release (49, 50) or block sarcoplasmic/endoplasmic
reticulum Ca2+-ATPase-mediated Ca2+ sequestration by the ER (51). During ER
stress, increased Ca2+ transfer from the ER to mitochondria leads to mitochondria
Ca2+ overload and generation of mitochondrial-derived ROS, which could further
disrupt protein folding in the ER and potentiate ER Ca2+ release through a positive
feed-forward mechanism (52, 53).
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Recent studies show that neurotoxins induce ER stress via the generation
of ROS (54, 55), suggesting that ER stress may be involved downstream of ROS.
The biological relevance of the neurotoxin induced-ER stress is still unknown.
Given that ER is an important regulator of intracellular Ca2+ homeostasis,
oxidant-induced deregulation of ER Ca2+ homeostasis could contribute to
dopaminergic degeneration.
Induction of ER stress proteins during oxidative and ER stress seems to be
important to remedy the perturbations of ER Ca2+ homeostasis. We previously
reported that Herp is essential for cell survival in response to ER stress (16). Here, we
found that Herp is critical for cellular stress adaptation in response to MPP+.
Consistent with this notion, we found that overexpression of Herp attenuated
MPP+-induced toxicity, whereas knockdown of Herp increased not only CHOP
expression but also ER Ca2+ leakage and mitochondrial Ca2+ accumulation, resulting
in cell death (Fig. 1). Notably, we found that MPP+ failed to up-regulate Herp
expression in dopaminergic cells in vitro (Fig. 2, A and B). Failure to induce a
compensatory increase in Herp expression may deteriorate ER function in MPP+treated cells. Hence, exploring ways to increase Herp expression can increase the
ability of dopaminergic cells to cope with ER stress and to protect from MPP+
toxicity.
Given that Herp plays a crucial role in stabilizing ER Ca2+ homeostasis (16, 17),
we determined whether stable expression of Herp counteracts MPP+-induced toxicity by
inhibiting Ca2+ transfer for ER to mitochondria. Time course analysis of the of the MPP +induced alterations in [Ca2+]ER and [Ca2+]M revealed that knockdown of Herp
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accelerates ER Ca2+ store depletion with a time course that parallels [Ca2+]M
accumulation (Fig. 3B) and that overexpression of Herp reversed the toxic Ca2+
transfer between the ER and mitochondria (Fig. 3, A and B). The mitochondrial
apoptotic pathway is an integral part of MPP+-induced apoptosis (24, 25). Excessive
accumulation of [Ca2+]M causes collapse of the mitochondria membrane potential,
which results in mitochondrial transition pore opening and release of proapoptogenic factors including cytochrome c that promotes downstream caspase
activation (53). Because mitochondria are linked to the ER both by proximity and
through Ca2+ signaling (52, 56), various pathological conditions that perturb ER
Ca2+ homeostasis could adversely impact the function of the mitochondria. Hence,
oxidant-induced damage to the ER could cause a protracted elevation in [Ca2+]M that
could enhance generation of mitochondrial-derived ROS that through a feed forward
mechanism exacerbates the loss of Ca2+ from the ER (53).
The underlying molecular and cellular mechanisms whereby Herp stabilizes
ER Ca2+ homeostasis and preserves mitochondrial function in MPP+-treated cells
remain to be established. It is unlikely that the ER membrane-associated Herp
functions as a calcium-binding chaperone analogous to Grp78 and calreticulin (14).
We excluded a role for Bcl-2 in the Herp-mediated stabilization of ER Ca2+
homeostasis based on the findings that Herp fails to bind to Bcl-2 and that total
levels of Bcl-2 in the microsome fractions were not significantly different in PC12-VT
and PC12-Herp cells (Supplemental Fig. S4). Hence, the mechanism by which
Herp maintains ER Ca2+ homeostasis appears to be different from the proposed antiapoptotic action of Bcl-2 (37). Because the UBL domain is essential for Herp-
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mediated protection against neurotoxins (Fig. 7B), we determined that the UBL
domain is essential for the ability of Herp to maintain ER Ca2+ homeostasis.
Expression of Herp lacking the UBL domain fails to stabilize intracellular Ca2+ and to
suppress the induction of CHOP in MPP+-treated cells (Fig. 7, C and D), indicating
that UBL is critical for the cytoprotective function of Herp.
How the UBL domain is involved in the protective function of Herp is not clear.
The presence of the UBL domain, which faces into the cytosol (14), suggests that
Herp may function as a proteasome-interacting domain, as has recently been
demonstrated for Parkin (57). Several recent studies support a role of Herp in ERAD
(38, 39). Herp interacts with Hrd1p, a membrane-anchored E3 ligase (38), and with
ubiquilin, a shuttle protein that delivers ubiquitinated substrates to the proteasome
for degradation (58). Overexpression of Herp enhances the degradation of the
ERAD substrate CD3o, whereas siRNA-mediated reduction of Herp expression
stabilized the ERAD substrate CD3γ but did not alter or increased degradation of
non-ERAD substrates tested (38). It is possible that Herp may target yet to be
identified CHOP-regulated ERAD substrates whose accumulation

results in

perturbations in ER Ca2+ homeostasis. Hence, elucidating the precise role of Herp
in ERAD and the identity of the ERAD substrates that accumulate in Herp
knockdown cells will likely provide clues to the mechanisms of Herp-mediated ER
Ca2+ stabilization and protection from MPP+-induced toxicity.
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Figures

Figure 3-1. Herp protects from MPP+ toxicity
(A) PC12 cells were transfected with siRNA targeting Herp (Herp;100 nM) or
nonsilencing control siRNA (Con;100 nM) for 24 and 48 h. For sequences of each
siRNA-Herp or siRNA-Con, see "Materials and Methods". Total protein lysates were
prepared and analyzed by immunoblotting using an anti-Herp antibody. Equal protein
loading was confirmed by reprobing immunoblots with an anti-ERK1 antibody. (B) PC12
cells and MN9D were transfected with siRNA-Herp or siRNA-Con (100 nM) for 24 h
prior to exposure to 0.5 mM MPP+ or vehicle. At the indicated time points, the
percentage of Trypan blue-positive cells in each culture was quantified. The values are
the means and S.D. of three independent experiments, *p<0.01, #p<0.05 (ANOVA with
Scheffe post-hoc tests) compared with vehicle-treated cultures. (C) PC12 clones were
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stably transfected with plasmid containing Herp (Herp) or the empty plasmid (VT). Total
protein lysates were analyzed in three independent clones by Western blotting using an
anti-Herp antibody. Equal protein loading was confirmed by reprobing the immunoblots
with an anti-ERK1 antibody. (D) Cultures of PC12-VT and PC12-Herp were left
untreated or treated for the indicated time points with 0.5 mM MPP+ or vehicle, and cell
viability was assessed. These results were expressed as percentage of Trypan bluepositive cells in each culture, normalized to untreated cultures. The values represent
mean  SD of 3 independent experiments, *p<0.01(ANOVA with Scheffe post-hoc
tests).
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Figure 3-2. MPP+ and tunicamycin induce Herp and CHOP expression with
different kinetics
PC12 (A) and MN9D (B) cells were treated with 0.5 mM MPP+ for the indicated time
points. Total RNA and cell lysates were prepared and analyzed by semi-quantitative
RT-PCR and immunoblotting for Herp and Grp78, respectively. As control (Ctrl) for
equal loading, actin mRNA and ERK1 protein were determined. Densitometric analyses
of protein bands are shown next to each panel. *p<0.01 (ANOVA with Scheffe post-hoc
tests) compared to untreated cultures. Asterisks indicated the full-length Herp protein.
(C) PC12 and MN9D cells were treated with 5 µg/ ml tunicamycin for the indicated time
points. Total lysates were prepared and analyzed by by semi-quantitative RT-PCR and
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immunoblotting for Herp and Grp78, respectively. Quantitation of the density of the
protein bandsis shown next to each panel, *p<0.01, (ANOVA with Scheffe post-hoc
tests) compared to untreated cells.

Figure 3-3. Herp counteracts MPP+-induced depletion of ER Ca2+ store
Statistical evaluations of the changes in the Ca2+ concentration in the ER ([Ca2+]ER) (A
and B) and mitochondria ([Ca2+]m) (C and D) in PC12 and MN9D cells (A and C) and in
the indicated stably tranfected PC12 clones (B and D) after treatment with MPP + . The
indicated cultures were transiently transfected with 2 µg YC4-ER or RP-mt for 24 h prior
to incubation with 0.5 mM MPP+. At the indicated time points, [Ca2+]ER and [Ca2+]m were
measured as described in Materials and Methods. The results were expressed as the
ratio of the YC4-ER or RP-mt fluorescence signals in MPP+-treated relative to untreated
120

cultures. Values are mean and S.D. of measurements made in three or four cultures
(n=4 dishes, 4-6 microscopic fields per dish, 25-30 cells per field), *p<0.01, #p<0.05
(ANOVA with Scheffe post-hoc tests) compared to either untreated cultures or PC12-VT
cultures. Representative pseudocolored images of the indicated PC12 clones at
baseline and after exposure to MPP+ are shown in B and D. The pseudocolor bar shows
the ratio range. Con, control.
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Figure 3-4. Herp counteracts MPP+-induced upregulation of CHOP
(A) Time course of CHOP and Grp78 protein levels in cultures of PC12-VT and PC12Herp before and after incubation with 0.5 mM MPP +. As control for equal loading,
immunoblots were reprobed with an antibody to ERK1. Densitometric analysis of protein
bands normalized to untreated control cultures is shown in the right panel. *p<0.01
(ANOVA with Scheffe post-hoc tests), compared to PC12-VT (B) Time course of MPP+induced CHOP mRNA and protein levels in cultures of PC12 cells transfected with
siRNA-Herp or siRNA-Con (100 nM). The cultures were incubated with 0.5 mM MPP+
24h after transfection. Actin and ERK1 were used as loading controls. Densitometric
analyses of protein bands normalized to untreated control cultures are shown in the
right panel. *p<0.01 (ANOVA with Scheffe post-hoc tests), compared to cultures
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transfected with siRNA-Con. (C and D) PC12 cells were transfected with siRNA-CHOP
or siRNA-Con (100 nM). One day after transfection, PC12 cells were exposed to 0.5
mM MPP+ or vehicle for the indicated time points and subsequently harvested for
detection of Herp mRNA and protein (C) or fixed for quantitation of cell death (D). Actin
and ERK1 were used as loading controls. Densitometric analyses of protein bands
normalized to untreated control cultures is shown in the right panel, *p<0.01 (ANOVA
with Scheffe post-hoc tests), compared with cultures transfected with siRNA-Con. For
quantitation of cell death, the percentages of Trypan blue-positive cells in each treated
culture, normalized to vehicle-treated cultures, were shown. The values are the means
and S.D. of three dishes per group for each time point, *p < 0.01, #p < 0.05 (ANOVA with
Scheffe post-hoc tests) compared to cultures transfected with siRNA-Con.
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Figure 3-5. CHOP and Herp modulates ER Ca2+ homeostasis in MPP+-treated cells
Knockdown of CHOP (A) and Herp (B) alters ER Ca2+ store contents in MPP+-treated
PC12 cells. Twenty-four hours after co-transfection with 2 µg pBudCE4.1-YC4-ER with
the indicated siRNA duplexes (100 nM), cultures were incubated with 0.5 mM MPP+ or
vehicle control (Con). Changes in ER Ca2+ concentration ([Ca2+]ER) were recorded at the
indicated time points as described in Materials and Methods and presented as the ratios
of the YC4-ER fluorescence signal in MPP+-treated relative to untreated cultures. The
values are mean and S.D. of measurements made in three separate cultures (n=4
dishes, 4-6 microscopic fields per dish, 25-30 cells per field), *p<0.01, #p<0.05 (ANOVA
with Scheffe post-hoc tests), compared to cultures treated with siRNA-Con.
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Figure 3-6. The ubiquitin-like (UBL)-domain is essential for Herp-mediated
stabilization of ER Ca2+ homeostasis and rescue from MPP+ toxicity
(A) Schematic diagram of full-length Herp protein and a deletion mutant lacking the
amino-terminal ubiquitin-like (UBL) domain (UBL-Herp). Expression of Herp and
UBL-Herp protein in stably transfected PC12 clones is shown in the inset. ERK1 was
used as the loading control. (B) UBL-Herp fails to rescue PC12 cells from MPP+
toxicity. The indicated PC12 clones were exposed to 0.5 mM MPP + for the indicated
time points. The results were expressed as percentage of Trypan blue-positive cells in
each culture, normalized to vehicle-treated cultures, from three independent
experiments, *p<0.01, #p<0.05 (ANOVA with Scheffe post-hoc tests). #p<0.05, (ANOVA
with Scheffe post-hoc tests), compared to PC12-VT. (C) UBL-Herp fails to stabilize ER
Ca2+ homeostasis. Twenty-four hours after transfection of pBudCE4.1-YC4-ER, the
indicated PC12 clones were incubated with 0.5 mM MPP +. Changes in ER Ca2+
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concentration ([Ca2+]ER) were recorded at the indicated time points as described in
Materials and Methods and presented as the ratio of the fluorescence signals in MPP +treated relative to untreated cultures. The values are mean and S.D. of measurements
made in three or four cultures (n=4 dishes, 4-6 microscopic fields per dish, 25-30 cells
per field), *p<0.01, (ANOVA with Scheffe post-hoc tests) compared to PC12-VT and
PC12-UBL-Herp. #p<0.05, (ANOVA with Scheffe post-hoc tests), compared to PC12VT. (D) UBL-Herp fails to suppress MPP+ induced upregulation of CHOP. Time course
of MPP+-induced increase in CHOP protein level in the indicated stably-transfected
PC12 clones. As control for equal loading, immunoblots were reprobed with an antibody
to ERK1. Densitometric analysis of protein bands normalized to untreated control
cultures is shown in the right panel. *p<0.01 (ANOVA with Scheffe post-hoc tests),
compared to PC12-VT and PC12-UBL-Herp.
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Figure 3-7. Proteasomal-mediated degradation is essential for Herp-dependent
stabilization of ER Ca2+ homeostasis and rescue from MPP+ toxicity
(A) The proteasomal inhibitor lactacystin abolishes Herp-mediated suppression of
CHOP in MPP+-treated PC12 cells. Time course of CHOP and Grp78 protein levels in
PC12-Herp cultures incubated with 0.5 mM MPP+ in the presence or absence of
lactacystin (5 µM). As control for equal loading, immunoblots were reprobed with an
antibody to ERK1. (B) Lactacystin abolishes the Herp-dependent suppression of ER
Ca2+ store depletion in MPP+-treated PC12 cells. Twenty-four hours after transfection
with 2 µg pBudCE4.1-YC4-ER, the cultures of PC12-Herp were incubated with 0.5 mM
MPP+ in the presence of lactacystin (5 µM) or its vehicle control. Changes in ER Ca 2+
concentration ([Ca2+]ER) were recorded at the indicated time points as described in
Materials and Methods and presented as the ratio of the YC4-ER fluorescence signal in
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MPP+-treated relative to untreated cultures. The values are the means and S.D. of
measurements made in three or four cultures (n=4 dishes, 4-6 microscopic fields per
dish, 25-30 cells per field), *p<0.01, (ANOVA with Scheffe post-hoc tests). (C and D)
Lactacystin enhances MPP+ toxicity (C) and reverses the Herp-dependent cell death
rescue from MPP+-toxicity (D). Cultures of PC12 (C) and PC12-Herp clones (D) were
exposed to 0.5 mM MPP+ in the presence of lactacystin (5 µM) or vehicle control for the
indicated time points. Shown is the percentage of Trypan blue-positive cells in each
culture, normalized to untreated cultures, from three independent experiments, *p<0.01,
(ANOVA with Scheffe post-hoc tests) compared to vehicle-treated cultures.

Supplementary Figure 3-1. MPP+ increases ROS accumulation
PC12 cells were loaded with the fluorescence probe, 7-dichlorodihydrofluorescein
diacetate (10 µM DCF-DA, Molecular Probes). Fluorescence images were acquired
using a confocal microscope and quantified (20). Values are the average DCF
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fluorescence pixel intensity per cell before and after exposure to 0.5 mM MPP + at the
indicated time periods. Values are mean ± S.D. of determinations made in four to five
cultures; 30–40 cells assessed in each culture, *p<0.01, #p<0.05 (ANOVA with Scheffe
post-hoc tests), compared to untreated cultures.

Supplementary Figure 3-2. Effect of CHOP knockdown on the survival of PC12Herp clones
The indicated PC12 clones were transfected with siRNA-CHOP or siRNA-Con (100
nM). One day after transfection, PC12 cells were exposed to 0.5 mM MPP + for the
indicated time points and fixed for quantitation of cell death. Results were expressed as
percentage of Trypan blue-positive cells in each culture, normalized to untreated
cultures. Values represent mean  SD of determinations made in four separate cultures,
*p<0.01, #p<0.05 (ANOVA with Scheffe post-hoc tests), compared to PC12-VT cultures.
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Supplementary Figure 3-3. The fluorescent indicators are properly targeted and
expressed in their respective organelles
(A) YC4-ER co-localizes with the ER marker calnexin before and after exposure to
MPP+ (0.5 mM). PC12 cells were transfected with YC4-ER, fixed and immunostained
with the calnexin antibody. Fluorescence images were acquired using a confocal
microscope. (B) Pericam-mt co-localizes with the vital dye MitoTracker red in PC12 cells
before and after exposure to MPP+ (0.5 mM). Pericam-mt transfected PC12 cells were
loaded with MitoTracker red and imaged using a confocal microscope.
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Supplementary Figure 3-4. The Herp-dependent protective mechanism is not
mediated by Bcl-2
(A) Time course of Bcl-2 protein in total cell lysates (upper panels) and microsomes
(lower panels) harvested from PC12-VT and PC12-Herp after incubation with 0.5 mM
MPP+. Microsomal fractions were isolated by differential centrifugation as described
previously (16). Equal protein loading was confirmed by reprobing the immunoblots for
ERK1 and calnexin (an ER-resident protein), respectively. (B). Herp fails to interact with
Bcl-2. A polyclonal mouse anti-Herp antibody was used for immunoprecipitation as
described in Materials and Methods. The Bcl-2 protein is detected in the input (whole
lysates) but not in the immune complexes bound to control IgG or Herp antibody. The
heavy chain of IgG is indicated as IgG-h.
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Supplementary Figure 3-5. Lactacystin treatment reduces proteasomal activity
PC12 cells were treated with 5 µM lactacystin or vehicle control. At the indicated time
points, chymotrypsin-like activity of the proteasome were assessed in whole cell lysates
using the fluorogenic peptide Suc-Leu-Leu-Val-Tyr-7-amino-4-methylcoumarin (LLVYAMC) according to the method reported previously (15). Values are the average
fluorescence intensity (360/440 nM) before and after exposure to 0.5 mM MPP+ at the
indicated time points. Values are mean ± S.D. of determinations made in four to five
dishes, *p<0.01 (ANOVA with Scheffe post-hoc tests), compared to vehicle-treated
cultures.
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Summary Diagram 3-1. Part 1. Schematic representation of MPTP entry into
dopaminergic nerurons
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Summary Diagram 3-2. Part 2. Schematic representation of the mechanisms
involved in toxicity of MPTP
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CHAPTER FOUR: ABERRANT ACCUMULATION OF -SYNUCLEIN WORSENS
ISCHEMIA-INDUCED BRAIN DAMAGE BY INCAPACITATING DJ-1–MEDIATED
NEUROPROTECTIVE RESPONSES
Introduction
Brain injury following cerebral ischemia or stroke results from the complex
interplay of multiple pathways including ionic imbalance and excitotoxicity, oxidative and
nitrative stress, and inflammation (1). Reactive oxygen species (ROS) are produced in
excess during the course of cerebral ischemia reperfusion (I/R) by a variety of
mechanisms such as aberrant electron transport in injured mitochondria, calcium influx
and inflammatory reactions (2). A growing body of evidence supports the essential role
of oxidative and nitrative stress in the initiation and progression of the injury process
after I/R (3). Reoxygenation during reperfusion activates nitric oxide synthase and
increases the generation of nitric oxide, which combines with superoxide to produce
peroxynitrite, a potent oxidant that can modify cellular targets (proteins, lipids, and DNA)
and participate in signaling mechanisms that result in exacerbation of infarct (4).
Oxidation-modified proteins have been shown to accumulate and participate in the
generation of protein aggregates (5).
Protein aggregation is part of the etiology of many chronic neurodegenerative
diseases such as Alzheimer's (AD), Parkinson’s (PD) and Huntington's (HD) diseases
although the causes of protein aggregation vary among the diseases (6). Abnormal
accumulation of protein aggregates also occurs after acute brain injury such as
ischemic stroke and has been detected in vulnerable neurons from the onset of I/R until
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delayed neuronal death (7, 8). The protein aggregates formed after cerebral ischemia
are detergent-resistant (7), consistent with the nature of irreversible protein aggregation
in other pathologic conditions. The role of protein aggregation in neuronal pathology
after brain ischemia is not clear. It is believed that protein aggregation may contribute to
delayed neuronal death as induction or transgenic overexpression of heat shock protein
70 (Hsp70) and other molecular chaperones before ischemia reduces evidence of
protein aggregation under conditions where neuronal survival is increased (9, 10).
PD is the second most prevalent neurodegenerative disorder and is
characterized pathologically by the relatively selective degeneration of midbrain
dopaminergic

neurons

and

the

accumulation

of

insoluble

-Syn

containing

intracytoplasmic inclusions called Lewy bodies (11, 12). -Syn was the first gene
identified whose mutations cause autosomal dominant forms of familial PD (13).
Overexpression of PD-causing mutant -Syn in animal models leads to -Syn
aggregation and neurodegeneration (14). Genetic and biochemical studies implicate
protein misfolding and aggregation, aberrant expression and degradation in α-Syninduced pathology (15, 16). -Syn is a small 140 amino acid presynaptic protein that is
intrinsically unfolded and assembles under pathological conditions into characteristic
Lewy

inclusion

bodies

that

typify

PD

and

other

Lewy

body-containing

neurodegenerative diseases termed synucleinopathies (16). Familial PD mutants of Syn have increased propensity to aggregate. (17). Furthermore, exposure to oxidizing
conditions has been shown to accelerate α-Syn aggregation (16). Specifically, nitration
of α-Syn protein accelerates its rate of fibrillization (16). Triplication of its gene locus has
also been identified in early onset familial PD suggesting that aberrant accumulation of
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-Syn can play a crucial role in PD pathogenesis (18). While the normal function of Syn continues to be characterized, multiple lines of evidence suggest that PD
pathogenesis is closely linked with a toxic gain of function associated with misfolded Syn.
DJ-1 is another PD gene linked to early onset disease with autosomal recessive
inheritance (12, 19). DJ-1 is a small 189 amino acid protein that is ubiquitously
expressed and exhibits anti-oxidant and chaperone-like activities (20-23). The DJ-1mediated protective actions have been demonstrated in several pathological disease
models both in vitro and in vivo (20-23). Consequently, PD-causing mutations that result
in loss of DJ-1 function expose dopaminergic neurons to endogenous and exogenous
stressors (19). Consistent with this notion, DJ-1 knockdown cells and DJ-1 null mice or
flies are highly susceptible to PD-inducing neurotoxins such as paraquat, 6hydroxydopamine, rotenone and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
(20-23). DJ-1 null mice also display larger infarcts as compared to wild-type mice in a
rodent model of ischemic stroke (24) suggesting that DJ-1 deficiency may concur in
exacerbating oxidative damage. Conversely, overexpression of DJ-1 correlated
positively with survival outcome (25).
Given that oxidative stress is an established mediator of ischemia-induced
neuronal injury and plays a critical role in mediating -Syn aggregate formation and
toxicity, and the recent findings that DJ-1 inhibits -Syn aggregate formation and
protects from ischemic brain damage (24), we explored the pathological interactions
between these two PD-associated proteins in the context of oxidative stress, protein
aggregation, and neuronal survival under ischemic conditions.
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Materials and Methods
Transient Middle Cerebral Artery (MCA) Occlusion
C57BL/6, α-Syn-/- transgenic (B6;129X-SncatmlRosl, Stock #3692) and nontransgenic control (129/Sv x C57BL/6; Jackson Labs, Bar Harbor) mice were housed in
a pathogen free facility, about 4-5 animals per cage in a temperature controlled room
with a 12 hour light/dark cycle and with food and water ad libitum. The generation of αSyn-/- mice was previously described (56). Male mice (10-12 weeks old) weighing 22–26
g were anaesthetized with 1.5% halothane in 70% N2O and 30% O2, and focal cerebral
ischemia was induced by occluding the left MCA by using the thread occlusion
technique, essentially as described (57). Briefly, a 5-0 nylon filament, with its tip
rounded by heating near a flame, was inserted through the external carotid artery stump
and advanced into the right internal carotid artery until it blocked the MCA blood flow.
Arterial blood pressure and cerebral blood flow were monitored during ischemia and the
first 20 min of reperfusion as described previously (57). Sixty min. after occlusion, the
filament was gently withdrawn to restore blood flow. Rectal temperature was monitored
and maintained at 37 ± 0.5 °C with a thermostatic blanket throughout the entire duration
of the surgical procedure and in the recovery period until the animals regained full
consciousness. Sham-operated animals were subjected to similar surgical procedures
without occlusion of the MCA. At 3-72 h post-ischemic reperfusion, the animals were
anesthesized with 5% halothane and sacrificed. The α-Syn-/- mice were compared to
their own non-transgenic controls in the 129 x C57BL/6 genetic background (F10-F12).
Morphological studies revealed no fundamental abnormalities in the adult brain thereby
excluding the possibility that germ line deficiency would bias stroke outcome.
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All

procedures and animal handling were approved by and conformed to the guidelines of
the Institutional Animal Care and Use Committee of the University of Central Florida.

Cerebral Infarct Volume Measurement
After cerebral ischemia reperfusion (I/R), mice were sacrificed and brains
removed. Two millimeter coronal sliced were made with a rodent brain matrix (Kent
Scientific Corp) and stained for 20 min at 37 °C with 2% 2,3,5-triphenyltetrazoliun
chloride monohydrate (TTC; Sigma) for detecting infarcted tissue (57) The total infarct
volume was obtained from integrating infarcted areas and correcting for brain edema.
Briefly, the sections were scanned and the infarcted area in each section was calculated
by subtracting the non-infarct area of the ipsilateral hemisphere from the area of the
contralateral hemisphere with NIH Image analysis software (Scion Image). Infarction
areas in each section were summed and multiplied by section thickness to give total
infarction volume.

Neurological Evaluation
The functional outcome of the stroke injury was determined blinded to the
treatment history of the mice using a 5 grade neurological deficit score (0, no deficit; 1,
failure to extend right paw; 2, circling to the right; 3, falling to the right; 4, lacking
spontaneous locomotion) as described previously (57). Mice were evaluated before
MCA occlusion to establish a baseline and at 24 h after I/R.
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Primary Cultures
Cultures of dissociated neocortical cells were prepared from brains of 18-d-old
mouse embryos as previously described (58). Briefly, cerebral hemispheres were
removed and incubated for 15 min in Ca2+- and Mg2+-free Hank's Buffered Salt Solution
(Invitrogen) containing 0.2% trypsin. Cells were dissociated by trituration and plated into
polyethyleneimine-coated plastic or glass-bottomed culture dishes containing Minimum
Essential Medium with Earle's salts supplemented with 10% heat-inactivated fetal
bovine serum and (in mM): 2 L-glutamine, 1 pyruvate, 20 potassium chloride, 10 sodium
bicarbonate, and 1 HEPES, pH 7.2. After cell attachment (3-6 h after plating), the culture
medium was replaced with maintenance medium (Neurobasal Medium containing 2%
B27 supplement and 0.5 μM glutamine, Invitrogen). Thereafter, maintenance medium
was changed every 3 days. Experiments were performed in 12-14-days old cultures.

Production of Lentivirus Particles and Infection of Neuron Cultures
The DJ-1 cDNA was amplified by PCR from its pcDNA3-based expression vector
and cloned into a Gateway entry vector (pENTR4; Invitrogen). The viral constructs were
obtained through homologous recombination between pENTR4-DJ-1 and the lentiviral
destination vector pLenti6/V5-DEST (ViralPowerTM Lentiviral Expression System;
Invitrogen). Cortical neurons in 48-well at around 70% confluence were infected with
105 genomic particles / cell of pLenti6-DJ1 or pLenti6-LacZ (lactosidase) and then kept
in regular complete medium.
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RNA Interference
Cortical cultures were transfected with prevalidated siRNA duplexes targeting
mouse DJ-1 and Syn (Dharmacon), or a scramble control siRNA (siRNA-Con; Ambion)
using Oligofectamine 2000 (Invitrogen) in Opti-MEM (Invitrogen) according to
manufacturer's protocol. To monitor knockdown, neurons were harvested and
processed for RT-PCR and Western blot analyses.

Oxygen Glucose Deprivation (OGD) Treatment
Cortical neuronal cultures were rinsed and incubated in glucose-free Locke's
buffer (in mM: NaCl, 154; KCl, 5.6; CaCl2, 2.3; MgCl2, 1.0; NaHCO3, 5; and HEPES,
5 mM; pH 7.2) in an anaerobic chamber (Billups-Rothenberg) containing 94% N2/ 5%
CO2/ 1% O2 (59). Control cultures not deprived of oxygen and glucose were placed in
Locke’s containing 5.5 mM glucose under a 95% air / 5% CO2 atmosphere. To
terminate OGD, cultures were removed from the anaerobic chamber and incubated in
the normal growth medium in the normoxic incubator. At various time points following
reoxygenation, cell lysates were prepared. In knockdown experiments, cultures were
trasnfected with siRNAs 12 h prior to OGD. In some experiments, the JNK (c-Jun Nterminal kinase) and p53 inhibitors, SP600125 (Calbiochem) and pifithrin-, were added
to cultures 2 h prior to OGD.

Immunoprecipitation
Tissues were solubilized in binding buffer containing 50 mM Tris–HCl (pH 7.4),
150 mM NaCl, 1 mM EDTA, 1 mM DTT, 0.2 mM phenylmethanesulfonyl fluoride, and
1.0% NP-40 as described previously (60). The homogenate was centrifuged at 20,000 ×
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g for 10 min. Solubilized proteins were adjusted to 0.1% NP-40 and incubated for 12 h
at 4 °C with normal pre-immune IgG or antibody to mouse DJ-1 and Syn. After an
additional incubation with protein A conjugated beads, the immune complexes were
then recovered by low speed centrifugation and washed extensively with the binding
buffer containing 0.1% NP-40. Immunoprecipitated proteins were eluted by boiling in
SDS-PAGE sampling buffer and analyzed by immunoblotting.

Immunoblotting
Detergent-soluble and -insoluble fractions were prepared from dissected
hemispheres by homogenization of samples with a Dounce homogenizer (50 strokes) in
8 volumes of ice-cold homogenization buffer [10 mM Tris HCl (pH 7.4), 150 mM NaCl,
5 mM EDTA, 0.5% Nonidet P-40, 10 mM Na-ß-glycerophosphate, and complete
protease inhibitor mixture (Roche). After homogenization, samples were rotated at 4 °C
for 30 min for complete lysis, then the homogenate centrifuged (10,000 g, 4 °C, 20 min.)
and the resulting pellet and supernatant fractions were collected. The pellet fractions
were washed t in lysis buffer containing 1% Triton X-100 on a shaker for 1 hour at 4°C,
and then centrifuged at 20,000 g at 4 °C for 10 minutes to obtain Triton X-100 -soluble
and -insoluble fractions. The resulting pellet was solubilized in lysis buffer containing 1%
SDS. Protein amounts in the obtained fractions were determined using the BCA kit
(Pierce). Protein samples were separated by sodium dodecyl sulfate-polyacrylamide gel
electrophoresis and blotted to nitrocellulose membranes (BioRad) as described (61). All
membranes were blocked with 5% non-fat dry milk in Tris-buffered saline (TBS)
containing 0.1% Tween-20 and incubated with the following primary antibodies: DJ-1
(Abcam or Chemicon); -Syn (Abcam or Millipore); ERK1/2 (Santa Cruz); phospho147

JNK1/2 and total JNK1/2 (Santa Cruz); p53 (Cell Signaling); PARP (Cell Signaling);
beta-Actin (Sigma). Protein bands were then detected using horseradish peroxidase
conjugated secondary antibodies (Jackson Immunoreseacrh) and visualized using the
enhanced chemiluminescent substrate kit (Pierce). The protein levels were quantified
using NIH Image analysis software (Scion Image).

Semi-Quantitative Reverse Transcriptase-PCR (RT-PCR)
Abundance of mRNAs was examined by RT-PCR. After indicated time points,
total RNA was extracted from dissected ipsilateral and contralateral hemispheres of
sham-operated and ischemic brains using the RNeasy Mini kit (Qiagen). To prevent
genomic DNA contamination, the isolated total RNA samples were treated with DNAse.
Complementary DNA was synthesized from 2.5 µg of total RNA using the Superscript III
system with oligo-dT primer (Invitrogen). The primer used were as follows: -Syn
(NM_009221) forward 5’-GTGGAGCAAAAATACATCTTT AG-3’ and reverse: 5’TGTACGCCATGGA

AGAGCA

;

GC-3’

5’GCTTCCAAAAGAGCTCTGGTCA-3′

DJ-1
and

(NM_007262.3.)

forward

reverse

5′-

GCTCTAGTCTTTGAGAACAAGC-3′ ; p53 (NM_011640) forward 5’-CACGTACTCTC
CTCCCCTCAAT-3’
(NM_007393):

and reverse 5’-AACT GCACAGGGCACGTCTT-3′ ; beta-Actin

forward

GCTCGAAGTCTA

5′-CCTAGGCACCAGGG

GAGCAACA-3′;

18S

rRNA

TGTGAT-3′

and

(NM_X00686):

reverse
forward

5′5’-

AGGGGAGAGCGGGTAAGAGA-3’-and reverse 5’-GGACAGGACTAGGCGGA ACA-3’;
GADPH (NM M32599): forward 5’-AGGCCGGTGCTGAGTATGTC-3’ and reverse 5’TGCCTGCTTCACCACCTTCT-3’. All reactions were performed in triplicate using
GADPH or 18S as internal controls. RT-PCR products were resolved on agarose gels
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stained with ethidium bromide. Relative quantification of gene expression was
performed by normalizing the fluorescence intensities of each band to those of internal
controls.

Immununohistochemistry
Ischemia-induced changes cellular distribution of -Syn and DJ-1 proteins were
evaluated by immunohisto-chemistry. Mice were anesthetized with sodium pentobarbital
(120 mg/kg, i.p) and perfused transcardially with 4% paraformaldehyde in saline. Brains
were removed and post-fixed overnight, and placed in 30% sucrose for 24 h (62).
Coronal sections (25 µm) were cut in a Leica cryostat and mounted on Superfrost slides
(VWR). Sections were incubated with phosphate buffered saline (PBS) containing 0.2%
(v/v) Triton X-100 and 5% goat or horse serum for 1 h. Subsequently, sections were
incubated overnight at 4 °C with a monoclonal antibody against mouse -Syn (Syn102;
EMD Millipore) or nitrated (Tyr39) -Syn (nSyn14; EMD Milipore), or a polyclonal
antibody against DJ-1 (Chemicon). Antibody binding was visualized with a secondary
anti-rabbit antibody conjugated to either fluorescein isothiocyanate (FITC) or anti-mouse
conjugated to Texas Red (Invitrogen). To stain the nuclei, sections or coverslips were
further incubated with the nucleic acid stain 4',6-diamidino-2-phenylindole (DAPI) in
PBS containing 1% RNase and 0.2% Triton X-100 for 10 min, and then mounted in
FluorSave aqueous mounting medium (Calbiochem). The immunofluorescent staining
was analyzed and documented using a Nikon Eclipse 80i microscope equipped with a
DXR1200C color digital camera. All images were acquired using the same laser
intensity and photodetector gain to allow quantitative comparisons of relative levels of
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immunoreactivity. For double immune-fluorescence staining, the primary antibodies
were incubated sequentially and processed further as described above.

Quantification of Cell Death
Cell death was assessed by using a lactate dehydrogenase (LDH) Cytotoxicity
Detection Kit (Roche) or by trypan blue exclusion. The LDH method quantifies cell death
in culture based on the measurement of LDH released into the growth medium when
cell membrane integrity is lost. Trypan blue stains only the cells with disrupted plasma
membrane integrity so these cells were considered dead. Dead cells were counted in
four microscopic fields per dish, with a minimum of 100 cells per field and results were
expressed as a percentage of the total number of cells. All of the experiments were
repeated at least three times without knowledge of treatment history.

Statistical Analysis
Values were expressed as mean ± SEM and comparisons between two groups
were statistically evaluated by the Student’s t test using the GraphPad Instut software.
The bonferroni correction was used when more than two groups were present. Results
are presented as means ± SEM.

P-value of less than 0.05 was considered to be

statistical significance.

Supplementary Methods
Primary glial cultures
Enriched primary glial cultures were prepared from whole brains of 1-day old
mice. After reaching confluence, microglia were isolated by shaking the flasks
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containing mixed glia for 5 h at 150 rpm. Enriched microglia were maintained in DMEM
containing 10% FBS and 1 mm sodium pyruvate. To obtain astroglia, the mixed glial
cultures, after the separation of microglia, were detached with trypsin-EDTA and seeded
in the same culture medium used for microglia. After at least six consecutive passages,
highly enriched astroglia were used for experiments. The purity of glial cultures was
routinely verified at >95% by Iba1 (microglia) and GFAP (astrocytes) immunoreactivity.

Proteasomal Activity Assay
Freshly prepared cortical homogenates (20 μg of protein) were diluted in 1x
assay buffer (5x reaction buffer: 250 mmol/L Tris–HCL pH 7.6, 5 mmol/L dithiothreitol,
50 mmol/L MgCl2, and 10 mmol/L ATP) with 10 μg of substrate III (Calbiochem) in a 96well plate. Reactions were carried out for 30 min. at 37°C and stopped by adding 5%
SDS. Chymotrypsin-like proteasomal activity was measured with a spectrofluorometer
via substrate consumption at 440 nm with an excitation wavelength of 380 nm. Three
independent reactions were performed for each sample in the presence or absence of
the selective proteasomal inhibitor lactacystin (1 μmol/L; BioMol). Proteasome activity
was calculated by subtracting the lactacystin-insensitive (or non-proteasome) peptidase
activity from total peptidase activity.

Results
Cerebral Ischemia Reperfusion (I/R) Alters -Syn Protein Level and Solubility
Given that mouse -Syn shares similar primary and secondary structures with
human -Syn and that the mouse protein forms amyloid fibrils in vitro (27), we
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determined whether -Syn constitutes a component of the protein aggregates in
ischemic brains. As aggregate-prone proteins accumulate in the insoluble pellet (P)fraction as the result of decreased detergent-solubility, we monitored the chronological
changes of -Syn protein in the detergent soluble (S)- and P-fractions obtained from the
cortices of mice. Sham-operated mice subjected to the same surgical procedures but
without induction of I/R were used as controls. Immunoblot analysis revealed a marked
and sustained accumulation of -Syn protein in the P-fractions prepared from the
ipsilateral ischemic cortices when compared to those from the contralateral nonischemic
cortices. Insoluble -Syn monomers and oligomers were detected as early as 3 h postI/R and their levels increase progressively up to 72 h post-I/R (Fig 1A). Though the
monoclonal -Syn antibody detected the -Syn dimer as the prominent oligomeric form
in the P-fractions, high molecular oligomers were also present though at substantially
lower levels (data not show). Levels of -Syn are not significantly altered in the S- and
P- fractions obtained from the cortices of sham-operated mice (data not shown).
Next, we examined the alterations in -Syn subcellular localization in the
ischemic lesions by immunohistochemistry. The diffuse neurophilic -Syn staining
observed in the contralateral non-ischemic neurons was replaced by discrete
circumscribed clumps of intense immunolabeling in both the neurophil and somata of
neurons in the ischemic lesions (Fig 1B). The observed somatic accumulation of -Syn
has also been described in MPTP-intoxicated mice (27) suggesting that the aberrant
accumulation and subsequent aggregation of α-Syn in the somata is likely attributed to
impaired axonal transport resulting from ATP deficits in the ischemic neurons.
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Application of the preabsorbed or omission of the -Syn antibody yields no appreciable
labeling (data not shown).
Because the nitratively modified form -Syn is less soluble and accumulates in
human Lewy bodies and other -Syn containing inclusions (16), we stained ischemic
brain sections with an antibody that recognizes the nitrated form of mouse α-Syn
(nSyn14). nSyn14 immunoreactivity was detected in the ipsilateral but not contralateral
cortices (Fig 1C) suggesting that α-Syn modifications resulting from I/R-associated
oxidative and nitrative stress play a critical role in facilitating α-Syn aggregation. No
appreciable Syn14 immunoreactivity was detected in the cortices of sham-operated
mice (data not shown). Collectively, these data suggest that abnormal cellular
accumulation of -Syn protein that can promote its self-aggregation is a pathological
event initiated after I/R.

-Syn is Upregulated in Neurons Subjected to Ischemic Insults In Vitro
The aberrant accumulation of -Syn in the S-and P-fractions (Fig 1A) suggests
that -Syn expression might be increased in ischemic neurons. As predicted, -Syn
mRNA levels were elevated in the ipsilateral but not contralateral cortices after I/R
(Suppl Fig 1A). Both -Syn mRNA and protein levels were increased in the primary
mouse cortical cultures after OGD (Suppl Fig 1B), an in vitro model of I/R. The OGDinduced upregulation of -Syn was more robust in neurons when compared to
astrocytes and microglia (Suppl Fig 1B) and this may account for the relatively much
weaker -Syn immunostaining of glial cells in ischemic brains (data not show).
Collectively, these data indicate that -Syn expression is induced specifically in the
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ischemic neurons and that -Syn upregulation may play a precipitating role in I/Rinduced neuronal injury.

Accumulation of Insoluble -Syn in the Ischemic Lesions is Independent of
Parkin and Proteasome Activity
Parkin is an ubiquitin ligase controlling the degradation of some protein
substrates by the proteasomes (28). Loss of function mutations in parkin gene cause
early-onset PD with autosomal recessive inheritance (35). In sporadic form of PD,
parkin has been shown to accumulate in the insoluble fraction (29). Recently, it has
been shown that parkin mitigates -Syn-induced neuronal cell death in animal and
tissue culture models (30), suggesting a functional relationship between these two PDassociated proteins. Although the mechanism by which parkin protects from -Syninduced cytotoxicity is not completely understood, parkin may regulate the normal
metabolism of -Syn or the clearance of pre-formed -Syn aggregates (30). To
determine whether the appearance of -Syn-positive inclusions in the ischemic brains
might be a consequence of decreased parkin solubility, we monitored the chronological
changes of -Syn protein in the S- and P-fractions of lesioned and non-lesioned
cortices. Parkin levels in the S-fractions were not markedly altered up to 12 h after I/R
(Suppl Fig 2; upper panel) suggesting that the appearance of insoluble -Syn in the
ischemic cortices at 3 h post-I/R (shown in Fig 1A) could not be attributed to decreased
parkin solubility. Prolonged reperfusion (>12h) appears to impact parkin solubility as
evidenced by the subtle changes in the amount of parkin in the S- and P-fractions
(Suppl Fig 2; lower panel). Because proteosomal alterations are often found in patients
with sporadic PD (11, 12) and may play a role in -Syn accumulation, we measured
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proteasome activity in the S-fractions obtained from the ischemic and non-ischemic
cortices (shown in Fig 1A). Though proteasome activity decreases progressively in the
ischemic cortices (Suppl Fig 2B), -Syn aggregate formation precedes the significant
reduction in proteasome activity indicating that -Syn accumulation and aggregation
may not be attributed to altered proteasome activity. Taken together, these results
suggest that under ischemic stress conditions decreased -Syn solubility may be
attributed to the robust expression of -Syn that self-aggregates in a pro-oxidant
environment.

Cerebral I/R Alters DJ-1 Solubility and Localization
Consistent with the notion that oxidative stress induces the expression of DJ-1
(20), we found that DJ-1 mRNA levels in the ipsilateral cortices increased markedly and
peaked at 18 h post-I/R (Fig 2A). By 24 h after reperfusion, mRNA levels of DJ-1
returned close to those seen in the cortices of sham-operated mice (Fig 2A). The
corresponding DJ-1 protein decreased in the S–fractions (Fig 2B,C) and accumulated
time-dependently in the -Syn containing P-fractions (Figs 1 and 2B,C) suggesting that
I/R decreases the solubility of these two PD-associated proteins and that accumulation
of insoluble DJ-1 parallels that of insoluble -Syn. By contrast, DJ-1 mRNA and protein
levels were not markedly altered in the contralateral cortices of I/R-treated mice when
compared to the cortices of sham-operated mice (Fig 2A-C). The increase of DJ-1
protein

in

the

ipsilateral

but

not

contralateral

immunofluorescent staining (Fig 2D).
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cortices

was

confirmed

by

DJ-1 is Recruited into Pathological -Syn-Containing Inclusions in the Ischemic
Lesions
Next, we determined whether the observed decrease in DJ-1 solubility after I/R
might be related to its interaction with -Syn in vulnerable neurons. First, we evaluated
the

cellular

localization

of

DJ-1

and

-Syn

in

the

ischemic

brains

by

immunohistochemistry. After I/R, DJ-1 immunolabeling pattern changes from a relatively
even distribution to a heterogenous granular pattern in the ipsilateral but not
contralateral cortices (Fig 3A). Double immunofluorescence labeling confirmed that DJ1 immunopositive granules were co-localized with the somatic -Syn inclusions in the
ischemic neurons (Fig 3A). The specificity of DJ-1 labeling was confirmed by omission
or preadsorption of the primary antibody (data not shown).
Next, we performed co-immunoprecipitation assay to determine whether the
interaction of DJ-1 with -Syn accounts for the observed altered subcellular localization
of DJ-1. Both proteins were readily detected in protein complexes immunoprecipitated
from the nonfractionated homogenates of the ipsilateral cortices but not those of the
contralateral cortices of ischemic brains (Fig 3B). Furthermore, nSyn14 was also
detected in the DJ-1 containing protein complexes (data not show) indicating the
association of DJ-1 with the less soluble modified form of -Syn. The specificity of the
observed interaction was verified in the samples incubated with pre-immune IgG or no
antibody (Con).

Knockdown of -Syn Prevents the Ischemia-Induced Decrease of DJ-1 Solubility
To further delineate the relationship between -Syn accumulation and decreased
DJ-1 solubility in ischemic neurons, siRNA experiments were performed to block the
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OGD-induced upregulation of -Syn in cultured mouse cortical neurons. Transfection
with siRNA targeting -Syn mRNA (-Syn siRNA) markedly suppressed the OGD–
induced accumulation of -Syn mRNA and protein (Fig 4A). Fluorescein-labeled control
siRNA (Con siRNA) with a scrambled sequence was used to determine the specificity of
knockdown and to confirm siRNA delivery to > 90% neurons (data not shown). As DJ-1
appears to function as a broad-spectrum neuroprotectant, it is conceivable that removal
of DJ-1 from the soluble cellular compartment where it normally exerts its actions results
in decreased amount of functional DJ-1 and thereby unfavorably impacts neuronal
survival. Consistent with this notion, we found that knockdown of -Syn not only inhibits
the accumulation of DJ-1 in the P-fraction (Fig 4B) but also improved the survival of
transfected neurons under ischemic stress conditions (Fig 4C). Knockdown of -Syn did
not increase DJ-1 mRNA levels suggesting that the increase in soluble DJ-1 protein
could not be attributed to the compensatory increase of DJ-1 expression (Fig 4D).
Collectively, these results indicate that the ischemia-induced upregulation of -Syn
drives the abnormal accumulation of DJ-1 in pathological inclusions and that protection
from ischemic stress is dependent on the sustained increase of DJ-1 in the soluble
cellular compartment.

DJ-1 Suppresses α-Syn Accumulation and Aggregate Formation in Ischemic
Neurons
Because DJ-1 has been shown to inhibit the generation of α-Syn aggregates (31,
32), we next examined the impact of DJ-1 knockdown on α-Syn solubility in mouse
cortical neurons under ischemic stress conditions. Treatment with the DJ-1 siRNA
markedly suppressed the OGD-induced increase of DJ-1 mRNA and protein levels in
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cortical cultures by 70 to 80% relative to those treated with the Con siRNA (Fig 5A).
Consequently, knockdown of DJ-1 resulted in the accumulation of insoluble -Syn (Fig
5B) and decreased neuronal survival after OGD (Fig 5C). To further determine whether
-Syn aggregate formation was facilitated as the result of decreased DJ-1 function, we
ectopically expressed DJ-1 in cortical neurons. Overexpression of DJ-1 inhibited the
accumulation of α-Syn (Fig 5D) and protected neurons from OGD-induced death (Fig
5E) suggesting that DJ-1 increases the threshold of ischemic neuronal death by
suppressing the accumulation of α-Syn and its subsequent self-aggregation. Hence,
decreased DJ-1 solubility may concur in triggering the accumulation of insoluble α-Syn
that in turn accelerates the depletion of DJ-1 from the soluble cellular compartment.

DJ-1 Counteracts Ischemia-Induced Activation of the p53 Pathway
Next, we determined the mechanism(s) through which the effects of α-Syn on
DJ-1 function might aggravate neuronal damage. Considering the critical role of DJ-1 in
reducing cellular oxidative stress, we reasoned that the tumor suppressor protein p53
might be an important downstream target of DJ-1 to counteract ischemic neuronal
death. p53 is a transcription factor that is known to propagate oxidant-induced death
signaling cascades as chemical inhibitors of p53 can rescue vulnerable neurons from
ischemic insults in vivo and in vitro (32, 33). Normally, p53 exists at a very low level but
is rapidly increased in response to a range of insults including oxidative stress and DNA
damage (33). The Jun N-terminal kinase 1/2 (JNK1/2) is known to be activated by
oxidative stress and increases p53 protein stability by phosphorylation (35). Knockdown
of DJ-1 promotes p53 activation in part through the activation of JNK1/2 (Fig 6A). The
OGD-induced increase of p53 was associated with apoptosis as evident by the
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cleavage of poly (ADP-ribose) polymerase (PARP), a substrate of caspase-3 (Fig 6A).
Pharmacological inhibition of JNK and p53 activation using SP600125 and pifitrin-,
respectively, significantly rescued DJ-1 siRNA transfected neurons from OGD-induced
death (Fig 6B) without significantly altering the expression of p53 (Fig 6C). Our results
therefore strengthen the notion that DJ-1 counteracts ischemia-induced apoptotic
signaling through the inhibition of redox-dependent p53 activation.

-Syn Deficiency Ameliorates Cerebral I/R Injury
If -Syn upregulation was indeed important in promoting ischemic brain damage,
we hypothesize that -Syn deficiency would ameliorate the extent of anatomical and
functional brain damage after cerebral ischemia. Accordingly, we evaluated lesion
development in mice with targeted disruption of the -Syn gene 24 h following I/R by
quantifying cerebral infarction and evaluating neurological function. -Syn-/- mice
developed smaller infarct compared to -Syn+/+ mice (Fig 7B). The smaller infarct was
associated with a faster recovery after stroke as measured by a neurological score (Fig
7B). These data indicate that -Syn-/- mice are less susceptible to I/R brain injury.
To confirm that -Syn accumulation negatively impacts neuronal survival after
I/R, cortical neurons from -Syn-/- and -Syn+/+ embryos were subjected to OGD. In line
with the -Syn knockdown studies, we observed that -Syn-/- cortical neurons were
significantly less vulnerable to OGD-induced cell death (Fig 7C).
Because -Syn aggregation interferes with DJ-1 solubility, we next examined DJ1 accumulation in the S- and P-fractions obtained from -Syn-/- and -Syn+/+ cortical
cultures under ischemic conditions. The amounts of DJ-1 in the P-fractions were
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substantially lower in -Syn-/- when compared with -Syn+/+ neurons after OGD (Fig
7D). Consistent with the finding that DJ-1 negatively modulates the p53 pathway under
ischemic stress, we found that the accumulation of p53 protein was markedly lower in Syn-/- when compared to -Syn+/+ neurons (Fig 7D).

Discussion
The development of effective protective strategies requires a comprehensive
understanding

of

the

diverse

mechanisms

of

ischemic

brain

damage.

Pathophysiological processes associated with neuronal death in stroke and chronic
neurodegenerative diseases are usually investigated independently. However, stroke
and degenerative diseases may have common links as disease mechanisms or genes
defined for one neurodegenerative condition might also be central in stroke. Stroke can
either instigate or accelerate latent or progressive neurodegenerative events and is a
known epidemiologic risk factor for Alzheimer’s disease (AD) (36). Whether stroke also
increases the risk of developing PD or vice versa is still controversial due to the
relatively small-scale studies and the confounding factors associated with PD
medications that can influence stroke susceptibility and outcome (37). As PD patients
also have symptoms not classically associated with movement such as cognitive
defects, it is possible that, small “silent” strokes may predispose PD patients to cognitive
impairments later in life (38). Because -Syn accumulates in neurons with age, it is
likely that a similar mechanism may contribute to the progressive susceptibility to
stroke-induced neuronal injury.
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-Syn toxicity is generally considered a consequence of its aggregation (11, 12).
It has been reported that both human and mouse α-Syn proteins are natively unfolded
and that, at higher doses or following exposure to oxidizing conditions, the mouse
protein adopts fibrillar amyloid structures resembling those comprising human wild-type
and PD-linked (A53T and A30P) mutant α-Syn (26). Supporting the notion that SNCA
gene amplifications or polymorphisms with resultant relatively higher levels of the
protein increase the risk for developing PD (18, 39), we found that the ischemia-induced
upregulation of endogenous α-Syn and its subsequent aggregation in the presence of
an oxidative environment plays an important role in the initiation of α-Syn driven
perturbations that negatively impact neuronal survival. Genetic ablation of -Syn
reduces brain damage and improves functional outcome in a mouse model of focal
ischemic stroke. Ablation or knockdown of -Syn also improves neuronal survival to an
ischemic challenge in vitro. The endangering consequence of -Syn accumulation has
also been demonstrated in complex I-induced death of dopaminergic neurons (27) and
-Syn-/- mice are resistant to the toxic effects of MPTP (40). Furthermore, α-Syn
pathologies following traumatic brain injury were also prevented in -Syn-/- mice (41).
Hence, elucidating the factor(s) responsible for driving the robust expression of -Syn in
ischemic neurons could lead to a feasible therapeutic strategy aimed at inhibiting -Syn
accumulation and the associated neurons loss not only after I/R but also in traumatic
brain injury, AD, PD and related disorders.
Although the underlying mechanisms remain to be determined, soluble oligomers
and insoluble inclusions formed in different neurodegenerative diseases have been
shown

to

inactivate

cellular

protective

mechanisms
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(42).

Biochemical

and

immunohistochemical data support a scenario where the ischemic stress-induced
accumulation of -Syn aggregates recruits DJ-1 into the insoluble inclusions and
thereby interferes with DJ-1 solubility and subcellular distribution, and hence, its ability
to execute broad-spectrum neuroprotective functions. Several studies provided
evidence that DJ-1 forms high molecular weight complexes with -Syn in brain tissues
from patients with PD and related disorders (43-46). Decreased DJ-1 solubility has been
demonstrated in human brain tissues of patients inflicted with PD-related diseases but
not normal control subjects (44).
Though the interaction between DJ-1 and -Syn has been explored previously as
a possible mechanism for DJ-1 accumulation into pathological inclusions in cellular
models of -Syn overexpression (38, 39) and in human brain tissues (44), our data
concurs with the interaction accounting for the altered DJ-1 solubility in ischemic
neurons. We cannot exclude the possibilities that the interaction between these two PDassociated proteins may be indirect and that the presence of accessory factors in the
ischemic neurons may be required for the observed interaction in vivo. It is noteworthy
that the DJ-1 chaperone activity is redox-dependent (31, 32) and thereby its interaction
with -Syn may be regulated in the context of oxidative stress under ischemic
conditions.
Decreased DJ-1 solubility leads to impaired cellular anti-oxidant responses
resulting in the aggravation of oxidative damage after I/R. DJ-1 can directly scavenge
radicals and becomes more acidic in the presence of an oxidative environment (20, 47).
The resulting acidic form of the molecule is present at significantly higher level in PD
and AD brains when compared to control subjects (47). DJ-1 has been demonstrated to
162

redistribute to the mitochondria wherein it regulates the activity of complex I and
protects against mitochondria damage (20). Consistent with this notion, DJ-1
overexpression has been shown to confer neuronal resistance towards stimuli that
promote mitochondria-dependent apoptosis (21-23). Hence, reduced DJ-1 solubility
may promote mitochondrial dysfunction and aggravate ROS production resulting in the
subsequent activation of p53, a redox-regulated transcription factor that propagates
death responses to oxidative stress. Support for a pivotal role of p53 in PD is provided
by the recent findings that mice that are either deficient in p53 (48) or treated with
pifithrin-

resist MPTP neurotoxicity (49). Activation of p53 is also essential for

neuronal death in cerebral ischemia as mice given pifithrin- exhibited increased
resistance of neurons to ischemic injury and excitotoxic damage (34). Consistent with
the notion that α-Syn aggregation (50) and DJ-1 deficiency (51) lead to the activation of
the p53 pathway, we found that -Syn-/- neurons exhibit less p53 accumulation following
OGD and that the OGD-induced increase of p53 was substantially suppressed after
ectopic expression of DJ-1. We demonstrated that the ischemic stress-induced -Syn
accumulation contributes in part to the increase of p53 through the activation of JNK
which in turn phosphorylates and stabilizes the p53 protein. Hence, DJ-1 likely
suppresses p53 activation by ameliorating oxidative stress under ischemic conditions.
Our data do not exclude the possible involvement of other DJ-1-mediated antioxidant
mechanisms responsible for increasing the threshold for ischemia-induced neuronal
death. DJ-1 has been reported to function as a co-activator required for the induction of
neuroprotective and detoxifying genes likely through the interaction with NF-E2-related
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factor (Nrf2), a transcription factor that coordinates the expression of a variety of
antioxidant enzymes (52).
DJ-1 has chaperone activity and can inhibit α-Syn aggregate formation through
the induction of heat shock protein 70 (Hsp70) (53), a stress inducible chaperone that
protects the brain from ischemic injury (9, 10). Ectopic expression of Hsp70 has been
shown to inhibit α-Syn fibril formation (54, 55). Consequently, decreased DJ-1 solubility
and diminished protein function not only aggravates oxidative stress but also facilitates
α-Syn aggregation that is accelerated by the pro-oxidant environment within ischemic
neurons. Although oxidation of DJ-1 is necessary for its chaperone activity, excessive
oxidation can lead to impaired activity and protein aggregation. Hence, we cannot
exclude the possibility that compromised DJ-1 function could be attributed to additional
mechanisms independent of the interaction with α-Syn. However, the differential
solubility and localization of DJ-1 in α-Syn-/- and α-Syn+/+ neurons under ischemic stress
provides compelling evidence that α-Syn accumulation plays an essential role in
compromising DJ-1 function either directly by physical interaction or indirectly through
the generation of oxidants.

In conclusion, although ischemic stroke has different

causes than the slowly progressive neurodegenerative disorders, many of the common
disease

mechanisms

may

come

into

play

after

cerebral

I/R.

Biochemical

characterization of the insoluble fractions from the ischemic lesions provides evidence
for -Syn and DJ-1 co-aggregation which unfavorably impacts neuronal survival by
interfering with DJ-1-mediated neuroprotective responses resulting in lowered threshold
for oxidative stress-induced death. Our results not only provide a novel perspective on
the potential pathogenic role of -Syn in cerebral I/R but also suggest that the
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mechanism of neuronal death in ischemic stroke might have similar features with those
of PD and related disorders.
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Figures

Figure 4-1. Impact of cerebral ischemia reperfusion (I/R) on -Syn protein level
and solubility
(A) Representative immunoblots (left) and results of densitometric analysis (right) of Syn protein levels in the detergent-soluble (S) and -insoluble (pellet; P) fractions
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obtained from the ipislateral and contralateral cortices of mice 3, 6, 12 (upper panels)
and 18, 24, 48, 72 h (lower panels) after I/R. Total protein loading in the S- and Pfractions was confirmed by reprobing the immunoblots for ERK1/2 or actin, respectively.
The ipsilateral cortex of sham-treated mice sacrificed 24 h after was included as control
(C). Asterisk indicates the detergent-resistant -Syn dimer. Values are the mean 
SEM.

n=4-6

mice;

*p

<

0.01

versus

ipsilateral.

(B,

C)

Representative

immunofluorescence images of sections from the ipsilateral and contralateral cortices
labeled with antibodies against (B) α-Syn and (C) nitrated α-Syn. Both α-Syn and
nitrated α-Syn immunoreactivities are shown in red and DAPI staining of the nuclei in
blue.
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Figure 4-2. Impact of cerebral ischemia reperfusion (I/R) on DJ-1 protein level and
solubility
(A) Representative gel images of DJ-1 and GADPH mRNA levels in the ipsilateral and
contralateral cortices of mice 3, 6, 12 (top) and 18, 24, 48, 72 h (bottom) after I/R. The
ipsilateral cortex of sham-treated mice sacrificed 24 h after was included as control (C).
GADPH is used as an internal control. PCR products amplified were separated on
ethidium bromide stained agarose gels. (B, C) Representative immunoblots (B) and
results of densitometric analysis (C) of DJ-1 protein in the detergent-soluble (S) and insoluble (pellet; P) fractions obtained from the ipsilateral and contralateral cortices of
mice 3, 6, 12 (top) and 18, 24, 48, 72 h (bottom) after I/R. Blots were stripped and
reprobed for ERK1/2 or actin to confirm equal protein loading. The ipsilateral cortex of
sham-treated mice sacrificed 24 h after was included as control (C). Values are the
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mean  SEM. n=4-6 mice; *p < 0.01. (D) Representative fluorescence images of DJ-1
immunostained sections of the ipsilateral and contralateral cortices 12 h after I/R. Note
that the uniform cytoplasmic staining (indicated by arrows in the inserts) in the
contralateral cortex differs from the heterogenous inclusion-like staining in the ipsilateral
cortex.

Figure 4-3. DJ-1 interacts and colocalizes with -Syn after cerebral ischemia
reperfusion (I/R)
(A) Representative fluorescence images of sections from the ipsilateral (top) and
contralateral cortices (bottom) doubly immunostained for DJ-1 (green) and -Syn (red).
Co-localization of both signals (yellow) is displayed in a merged image. DAPI (blue) was
used to stain the nuclei. (B) Co-immunoprecipitation analysis of the interaction of DJ-1
and -Syn in Triton X-100 soluble homogenates (100 μg total protein) of contralateral
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(top) and ipsilateral (bottom) cortices 24 h after I/R. Samples were pre-cleared and
subjected to immunoprecipitation with preimmune IgG and antibodies to DJ-1 and Syn. As an additional control (Con), the antibody was left out. Immune complexes were
subjected to immunblot analysis with antibodies to DJ-1 and -Syn.

Figure 4-4. Impact of α-Syn knockdown on DJ-1 protein solubility and neuronal
vulnerability to oxygen-glucose deprivation (OGD)
(A) RT-PCR (top) and immunoblot (bottom) analyses of α-Syn mRNA and protein levels
in primary mouse cortical neurons that were transfected with either a siRNA targeting αSyn (α-Syn siRNA; 5 nM) or nontargeting control siRNA (Con siRNA; 5 nM) 18 h prior to
OGD. Neurons were collected at the indicated time points during reoxygenation. 18S
rRNA and ERK were used as internal controls. (B) Representative immunoblots of DJ-1
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protein levels in the detergent-soluble (S) and -insoluble (pellet; P) fractions obtained
from cortical neurons that were transfected with the indicated siRNAs 18 h prior to
OGD. Neurons were collected at the indicated time points during reoxygenation. Blots
were stripped and reprobed for ERK1/2 or actin to confirm equal protein loading. (C)
Histogram shows the viability of cortical neurons transfected with the indicated siRNAs
after OGD.

Cell death was quantified 12 and 24 h during reoxygenation. Values

represent the mean ± SEM of three separate experiments. #p<0.05, *p<0.01 versus
Con-siRNA. (D) Representative gel images of DJ-1 and 18S rRNA mRNA levels in
cortical neurons that were transfected with the indicated siRNAs 18 h prior to OGD.
Neurons were collected at the indicated time points during reoxygenation.

Figure 4-5. Impact of DJ-1 knockdown on α-Syn solubility and neuronal
vulnerability to oxygen-glucose deprivation (OGD)
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(A) RT-PCR (top) and immunoblot (bottom) analyses of DJ-1 mRNA and protein levels
in primary mouse cortical neurons that were transfected with either a siRNA targeting
DJ-1 (DJ-1 siRNA; 5 nM) or nontargeting control siRNA (Con siRNA; 5 nM) 12 h prior to
OGD. Neurons were collected at the indicated time points during reoxygenation. 18S
rRNA and ERK were used as internal controls. (B) Representative immunoblots of αSyn protein levels in the detergent-soluble (S) and -insoluble (pellet; P) fractions
obtained from cortical neurons that were transfected with the indicated siRNAs 12 h
prior to OGD. Neurons were collected at the indicated time points during reoxygenation.
Blots were stripped and reprobed for ERK1/2 or actin to confirm equal protein loading.
(C, D) Histogram shows the impact of DJ-1 knockdown (C) or overexpression (D) on
neuronal vulnerability to OGD. Cortical neurons were transfected with the indicated
siRNAs or infected with pLenti6-DJ-1 or pLenti-LacZ. Eight hours after siRNA
transfection or forty eight hours after infection, neurons were subjected to OGD. Cell
death was quantified 12 and 24 h during reoxygenation. The values are the mean ±
SEM of three-independent experiments. #p<0.05, *p<0.01 versus the respective
controls. (E) RT-PCR (top) and immunoblot (bottom) analyses of DJ-1 mRNA and
protein levels in cortical neurons that were infected with pLenti6-DJ-1 or pLenti6-LacZ
48 h prior to OGD. Neurons were collected at the indicated time points during
reoxygenation. 18S rRNA and actin were used as internal controls.
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Figure 4-6. DJ-1 suppresses p53 activation in neurons subjected to oxygenglucose deprivation (OGD)
(A) Representative immunoblots of phospho-JNK1/2, total JNK1, p53 and PARP
protein levels in cortical neurons that were transfected with either a siRNA targeting DJ1 (DJ-1 siRNA; 5 nM) or non-targeting control siRNA (Con siRNA; 5 nM) 12 h prior to
OGD. Neurons were collected at the indicated time points during reoxygenation. Blots
were stripped and reprobed for ERK1/2 or actin to confirm equal protein loading. (B)
Histogram shows the impact of pharmacological inhibition of JNK1 and p53 on neuronal
vulnerability to OGD-induced death. Cortical neurons were treated with SP6001 (10 μM)
or pifitrin-

(200 μM) 2 h prior to OGD. Cell death was quantified 24 h during

reoxygenation. The values are the mean ± SEM of three-independent experiments.
*p<0.01 versus respective vehicle controls. (C) Representative gel images of p53 and
GADPH mRNA levels in cortical neurons that were transfected with the indicated
siRNAs 12 h prior to OGD. Neurons were collected at the indicated time points during
reoxygenation.
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Figure 4-7. Syn gene ablation ameliorates cerebral ischemia reperfusion (I/R)
injury
(A) Representative images of brain sections from -Syn-/- and -Syn+/+ mice 48 h after
I/R that were stained with 2,3,5-triphenyltetrazoliun chloride monohydrate (TTC). (B) Bar
graphs show the infarct volume (left) and neurological scores (right). The values are the
mean ± SEM of 6-8 mice. *p<0.01 versus -Syn+/+. (C) Histogram shows the impact of
Syn gene ablation on neuronal vulnerability to oxygen-glucose deprivation (OGD)induced death. Cell viability was quantified 24 and 48 h during reoxygenation. The
values are the mean ± SEM of three-independent experiments. *p<0.01 versus Syn+/+. (D) Representative immunoblots (left) and results of densitometric analysis
(right) of protein levels of -Syn and DJ-1 in the detergent-soluble (S) and -insoluble
(pellet; P) fractions obtained from -Syn-/- and -Syn+/+ cortical neurons after OGD.
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Neurons were collected at 6 h during reoxygenation. Total p53 protein level in total
lysates is shown in the lower panel.

The values are the mean ± SEM of three-

independent experiments. #p<0.05,*p<0.01 versus -Syn+/+.

Supplementary Figure 4-1. -Syn is up-regulated in brains and cultured neurons
under ischemic stress
(A) RT-PCR analysis of -Syn mRNA expression in the ipsilateral and contralateral
cortices after cerebral ischemia reperfusion at the indicated time points. Histogram
shows the relative change in -Syn mRNA levels. Data were normalized on the basis of
GADPH mRNA levels. Values represent mean ± SEM. n=4-6 mice, *p < 0.01 versus
contralateral. (B) Time course of -Syn mRNA (left) and protein (right) levels in cultured
cortical neurons, microglia and astrocytes subjected to oxygen-glucose deprivation
followed by reoxygenation for the indicated time points. Control cultures (Con) were left
at 21% of O2 and in medium containing 25 mM of glucose.
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Supplementary Figure 4-2. Effects of ischemia on parkin protein level and
proteasome activity
(A) Representative immunoblots of the time course of parkin protein in the detergentsoluble (S) and -insoluble (pellet; P) fractions obtained from the ipsilateral and
contralateral cortices of mice (n=4-6) subjected to cerebral ischemia reperfusion at the
indicated time points. Blots were stripped and reprobed for ERK1/2 or actin to confirm
equal protein loading. The ipsilateral cortex of sham-treated mice was included as
control (C). (B) Proteasome activity in whole cortical homogenates was assayed with 50
µM succinyl-LLVY-AMC substrate in the presence or absence of 20 µM lactacystin.
Release of fluorescent AMC was measured by at λ=460 nm using a spectral fluorimeter
and proteasome activity was calculated by subtracting the lactacystin-insensitive (or
nonproteasome) peptidase activity from total peptidase activity. Data are mean ± SEM.
N=4-6 mice. #p<0.05, *p<0.01 versus contralateral.
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Summary Diagram 4-1. Schematic representation of the pathological processes
involved in ischemic brain injury
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